<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurochem Res</journal-id><journal-id journal-id-type="iso-abbrev">Neurochem Res</journal-id><journal-title-group><journal-title>Neurochemical Research</journal-title></journal-title-group><issn pub-type="ppub">0364-3190</issn><issn pub-type="epub">1573-6903</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39549173</article-id><article-id pub-id-type="pmc">PMC11569012</article-id>
<article-id pub-id-type="publisher-id">4276</article-id><article-id pub-id-type="doi">10.1007/s11064-024-04276-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>ATP Restoration by ATP-Deprived Cultured Primary Astrocytes</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0492-5257</contrib-id><name><surname>Karger</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0000-9918-0723</contrib-id><name><surname>Willker</surname><given-names>Johanna Elisabeth</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8659-8936</contrib-id><name><surname>Harders</surname><given-names>Antonia Regina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2811-8118</contrib-id><name><surname>Watermann</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7869-1305</contrib-id><name><surname>Dringen</surname><given-names>Ralf</given-names></name><address><email>ralf.dringen@uni-bremen.de</email><email>dringen@uni-bremen.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04ers2y35</institution-id><institution-id institution-id-type="GRID">grid.7704.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 4381</institution-id><institution>Centre for Biomolecular Interactions Bremen Faculty 2 (Biology/Chemistry), </institution><institution>University of Bremen, </institution></institution-wrap>P.O. Box 330440, 28334 Bremen, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04ers2y35</institution-id><institution-id institution-id-type="GRID">grid.7704.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 4381</institution-id><institution>Centre for Environmental Research and Sustainable Technologies, </institution><institution>University of Bremen, </institution></institution-wrap>P.O. Box 330440, 28334 Bremen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>50</volume><issue>1</issue><elocation-id>13</elocation-id><history><date date-type="received"><day>31</day><month>7</month><year>2024</year></date><date date-type="rev-recd"><day>9</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">A high cellular concentration of adenosine triphosphate (ATP) is essential to fuel many important functions of brain astrocytes. Although cellular ATP depletion has frequently been reported for astrocytes, little is known on the metabolic pathways that contribute to ATP restoration by ATP-depleted astrocytes. Incubation of cultured primary rat astrocytes in glucose-free buffer for 60&#x000a0;min with the mitochondrial uncoupler BAM15 lowered the cellular ATP content by around 70%, the total amount of adenosine phosphates by around 50% and the adenylate energy charge (AEC) from 0.9 to 0.6. Testing for ATP restoration after removal of the uncoupler revealed that the presence of glucose as exclusive substrate allowed the cells to restore within 6&#x000a0;h around 80% of the initial ATP content, while coapplication of adenosine plus glucose enabled the cells to fully restore their initial ATP content within 60&#x000a0;min. A rapid but incomplete and transient ATP restoration was found for astrocytes that had been exposed to adenosine alone. This restoration was completely prevented by application of the pyruvate uptake inhibitor UK5099, the respiratory chain inhibitor antimycin A or by the continuous presence of BAM15. However, the presence of these compounds strongly accelerated the release of lactate from the cells, suggesting that the ribose moiety of adenosine can serve as substrate to fuel some ATP restoration via mitochondrial metabolism. Finally, the adenosine-accelerated ATP restoration in glucose-fed astrocytes was inhibited by the presence of the adenosine kinase inhibitor ABT-702. These data demonstrate that astrocytes require for a rapid and complete ATP restoration the presence of both glucose as substrate and adenosine as AMP precursor.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Astrocytes</kwd><kwd>ATP restoration</kwd><kwd>Glycolysis</kwd><kwd>Adenosine</kwd><kwd>Metabolism</kwd><kwd>Mitochondria</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;t Bremen (1013)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Astrocytes are essential partners of neurons in the brain [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. To maintain their many important functions in the brain, astrocytes require substantial amounts of ATP, especially for processes such as the maintenance of the astrocytic membrane potential [<xref ref-type="bibr" rid="CR4">4</xref>], neurotransmitter uptake and metabolism [<xref ref-type="bibr" rid="CR5">5</xref>], ATP-driven export processes [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>] as well as the synthesis of energy stores such as glycogen [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] and lipid droplets [<xref ref-type="bibr" rid="CR10">10</xref>]. Thus, the maintenance of a high cellular ATP content and the continuous regeneration of the consumed ATP are highly important to fuel the astrocytic contributions for normal brain function. Accordingly, astrocytes are, at least in culture, able to metabolize a large variety of endogenous and exogenous substrates to maintain a high ATP level [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>] and use both cytosolic substrate level phosphorylation and mitochondrial oxidative phosphorylation for ATP regeneration [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par3">ATP is regenerated from ADP mainly by cytosolic glycolysis and by mitochondrial oxidative phosphorylation in brain cells. The importance of glycolysis for astrocytic ATP regeneration is clearly demonstrated by the observation that astrocytes can even survive an inactivated mitochondrial respiratory chain in culture and in vivo as purely glycolytic cells [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Thus, glycolysis appears to be sufficient to regenerate the needed ATP in astrocytes as long as glucose availability is not limited. On the other hand, glucose-deprived astrocytes maintain a high ATP content for many hours by making use of endogenous energy stores as fuels for mitochondrial oxidative phosphorylation [<xref ref-type="bibr" rid="CR12">12</xref>]. In addition, the presence of various exogenous substrates can prevent the cellular ATP loss observed for astrocytes during extended glucose-deprivation by serving as substrates for mitochondrial ATP regeneration, including monocarboxylates, fatty acids and several amino acids [<xref ref-type="bibr" rid="CR13">13</xref>]. The contribution of both glycolysis and oxidative phosphorylation for maintaining a high ATP content is also demonstrated by the partial depletion of the cellular ATP level after inhibition of mitochondrial oxidative phosphorylation in glucose-fed astrocytes [<xref ref-type="bibr" rid="CR12">12</xref>], by the partial ATP regeneration via mitochondrial processes in astrocytes that had been treated with 2-deoxyglucose [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and by the severe cellular ATP loss reported for the impairment of both metabolic processes [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par4">Cultured astrocytes contain a high cytosolic ATP concentration of around 7 mM [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], but only low amounts of ADP and AMP [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>] that account to around 8% (0.56 mM) and 5% (0.35 mM) of the cytosolic ATP concentration, respectively [<xref ref-type="bibr" rid="CR14">14</xref>]. This leads to an adenylate energy charge (AEC: ([ATP]&#x02009;+&#x02009;0.5 [ADP]) / ([ATP] + [ADP]+ [AMP])) [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>] of around 0.9 in untreated cultured astrocytes [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. A rapid loss in cellular ATP content was reported for glucose-deprived astrocytes during coincubations with the mitochondrial respiratory chain inhibitor antimycin A [<xref ref-type="bibr" rid="CR14">14</xref>]. This loss was accompanied by some increase in cellular ADP and AMP levels, while the sum of the three adenosine phosphates (ATP&#x02009;+&#x02009;ADP&#x02009;+&#x02009;AMP) and the AEC were found severely decreased [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par5">Although ATP depletion by compromising metabolic pathways has been well studied for cultured astrocytes, hardly any information is available on the ATP restoration in astrocytes that had been partially depleted of ATP. To our knowledge, only few studies reported such data and described a rather limited potential of ATP depleted astrocytes for ATP restoration [<xref ref-type="bibr" rid="CR30">30</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref>]. In order to gain more information on astrocytic ATP restoration, we first depleted cultured astrocytes of ATP by a 60&#x000a0;min preincubation with the mitochondrial uncoupler BAM15 in glucose-free buffer as recently described [<xref ref-type="bibr" rid="CR18">18</xref>] and studied then ATP restoration after removal of the uncoupler and application of suitable substrates. ATP-deprived astrocytes almost completely restored their initial ATP level within 6&#x000a0;h after application of glucose in a process that was strongly accelerated by the presence of adenosine. Also, the presence of adenosine in the absence of glucose allowed a concentration-dependent rapid ATP restoration during 60&#x000a0;min, but this restoration was partial, significantly lowered by inhibitors of adenosine metabolism and not persistent during longer incubations. In addition, inhibitors of mitochondrial pyruvate uptake or of the respiratory chain did not affect ATP restoration in the presence of glucose but prevented ATP restoration from adenosine as exclusive substrate. These data demonstrate that glycolytic glucose metabolism enables ATP-depleted astrocytes to rapidly restore ATP in the presence of adenosine as AMP precursor, while ATP restoration from extracellular adenosine alone in the absence of glucose requires mitochondrial processes to make also use of the ribose moiety in adenosine as energy substrate.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec3"><title>Materials</title><p id="Par6">The adenosine deaminase inhibitor 2&#x02019;-deoxycoformycin (DCF), adenylate kinase, AMP, antimycin A, BAM15, fetal calf serum (FCS), glucose-6-phosphate, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2&#x000a0;H-tetrazolium bromide (MTT), the redox cyclers phenazine ethosulfate (PES) and phenazine methosulfate (PMS) as well as glucose-free Dulbecco&#x02019;s modified Eagles medium (DMEM) were obtained from Sigma-Aldrich (Steinheim, Germany). DMEM (containing 25 mM glucose) and penicillin G/streptomycin sulfate solution were purchased from Thermo Fisher Scientific (Schwerte, Germany). Acetate, bovine serum albumin, dimethyl sulfoxide (DMSO), NAD<sup>+</sup>, NADH and NADPH were obtained from AppliChem (Darmstadt, Germany). ATP, glutamate-pyruvate transaminase, lactate dehydrogenase (LDH), pyruvate kinase and yeast glucose-6-phosphate dehydrogenase were purchased from Roche Diagnostics (Mannheim, Germany). Nicotinamide was from Fluka (Steinheim, Germany). The adenosine kinase inhibitor ABT-702 and the purine nucleoside phosphorylase inhibitor forodesine hydrochloride were obtained from MedChemExpress (Monmouth Junction, NJ, USA). The Cell Titer Glo<sup>&#x000ae;</sup> 2.0 ATP Assay Kit was from Promega (Walldorf, Germany) and UK5099 from Merck (Darmstadt, Germany). All other basal chemicals were obtained from Sigma-Aldrich (Steinheim, Germany), Roth (Karlsruhe, Germany) or Merck (Darmstadt, Germany). Sterile cell culture consumables, unsterile 96-well plates and black microtiter plates were purchased from Sarstedt (N&#x000fc;mbrecht, Germany).</p></sec><sec id="Sec4"><title>Astrocyte-Rich Primary Cultures</title><p id="Par7">Primary astrocyte-rich cultures were prepared from the brains of newborn Wistar rats as previously described in detail [<xref ref-type="bibr" rid="CR33">33</xref>]. The rats were purchased from Charles River Laboratories (Sulzfeld, Germany) and treated in accordance to the State of Bremen, German and European animal welfare acts. The harvested cells were counted and 300,000 viable cells were seeded in 1 mL culture medium (90% DMEM containing 25 mM glucose, 44.6 mM sodium bicarbonate, 1 mM pyruvate, 20 U/mL penicillin G, 20&#x000a0;&#x000b5;g/mL streptomycin sulfate, supplemented with 10% FCS) in wells of 24-well dishes. The cells were incubated in the humidified atmosphere of a CO<sub>2</sub> incubator (Sanyo, Osaka, Japan) containing 10% CO<sub>2</sub>. The culture medium was renewed every seventh day and one day prior to an experiment. For experiments, confluent primary astrocyte cultures of an age between 14 and 28 days after seeding were used. Astrocyte-rich primary cultures are strongly enriched in astrocytes and contain only low numbers of contaminating other types of glial cells [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref>].</p></sec><sec id="Sec5"><title>Experimental Incubation of Cultured Astrocytes</title><p id="Par8">If not stated otherwise, astrocyte cultures in wells of 24-well dishes were washed twice with 1 mL pre-warmed (37&#x000a0;&#x000b0;C) glucose-free incubation buffer (IB; 145 mM NaCl, 20 mM HEPES, 5.4 mM KCl, 1.8 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 0.8 mM Na<sub>2</sub>HPO<sub>4</sub>, pH adjusted with NaOH to 7.4 at 37&#x000a0;&#x000b0;C). Subsequently, the cells were incubated for 60&#x000a0;min in 250 &#x000b5;L IB with 1 &#x000b5;M of the uncoupler BAM15 at 37&#x000a0;&#x000b0;C in the humidified atmosphere of a CO<sub>2</sub>-free incubator to deprive the cells of ATP. To study ATP restoration after the BAM15 treatment, the cells were washed twice with 1 mL pre-warmed (37&#x000a0;&#x000b0;C) glucose-free IB to remove the uncoupler and incubated in 250 &#x000b5;L IB containing substrates and/or inhibitors as indicated in the legends of the figures and tables for up to 6&#x000a0;h in the humidified atmosphere of a CO<sub>2</sub>-free incubator (37&#x000a0;&#x000b0;C). After the given incubation periods, the incubation media were harvested to test for potential toxicity of the incubation conditions by measuring the activity of extracellular LDH and to determine lactate contents. The cells were washed twice with 1 mL ice-cold (4&#x000a0;&#x000b0;C) phosphate-buffered saline (PBS; 10 mM potassium phosphate buffer pH 7.4 containing 150 mM NaCl) and lysed for quantification of ATP and other cellular metabolites.</p></sec><sec id="Sec6"><title>Determination of Cellular Contents of ATP, ADP and AMP</title><p id="Par9">The cellular contents of ATP, ADP and AMP were determined in perchloric acid lysates of cultured astrocytes as previously described in detail [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Briefly, the washed cultures were lysed in 400 &#x000b5;L of ice-cold 0.5&#x000a0;M HClO<sub>4</sub> on ice for 5&#x000a0;min. The lysates were collected and neutralized by adding 2&#x000a0;M KOH. ATP in the lysate was determined as recently described [<xref ref-type="bibr" rid="CR11">11</xref>] by a luciferin-luciferase-based luminometric assay using the Cell Titer Glo<sup>&#x000ae;</sup> 2.0 ATP Assay Kit. The ADP and AMP present in the lysates were converted by enzymatic reactions to ATP as recently described in detail [<xref ref-type="bibr" rid="CR14">14</xref>] that was also quantified by the luminometric ATP assay. The specific cellular contents of the three adenosine phosphates were calculated by normalizing the determined cellular contents to the respective initial cellular protein contents of the cultures.</p></sec><sec id="Sec7"><title>Determination of Cellular Contents of Nicotinamide Coenzymes</title><p id="Par10">The cellular contents of NAD<sup>+</sup>, NADH, NADP<sup>+</sup> and NADPH were determined in alkaline lysates [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] by modified protocols of reported enzymatic cycling assays [<xref ref-type="bibr" rid="CR17">17</xref>]. Control experiments revealed that the NAD(H) (sum of NAD<sup>+</sup> plus NADH) cycling assay used is specific for the detection of NAD<sup>+</sup> and NADH and does not give any signals in the presence of NADP<sup>+</sup> or NADPH, while the NADP(H) (sum of NADP<sup>+</sup> plus NADPH) cycling assay used is specific for NADP<sup>+</sup> and NADPH and does not give any signals in the presence of NAD<sup>+</sup> or NADH (data not shown).</p><p id="Par11">After a given treatment, cultured astrocytes were lysed for the quantification of the four nicotinamide coenzymes in 500 &#x000b5;L alkaline extraction buffer (20 mM NaHCO<sub>3</sub>, 100 mM Na<sub>2</sub>CO<sub>3</sub>, 15 mM nicotinamide, 0.05% Triton X-100, pH 11) for 10&#x000a0;min on ice in the dark. The lysed cells from two wells were pooled and homogenized in an ice-cooled ultrasonication water bath with 35&#x000a0;kHz (Sonorex, Bandelin, Berlin, Germany) for 5&#x000a0;min. Subsequently, 250 &#x000b5;L of the homogenized lysate was heated for 30&#x000a0;min at 60&#x000a0;&#x000b0;C to completely destroy the oxidized coenzymes NAD<sup>+</sup> and NADP<sup>+</sup>, while the reduced coenzymes remain intact [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par12">For determination of NAD(H), 50 &#x000b5;L of the heated alkaline lysates (for the quantification of NADH), of the not heated alkaline lysates (for the quantification of NADH plus NAD<sup>+</sup>) or of NADH standards (0-100 pmol/50 &#x000b5;L alkaline extraction buffer) were diluted in wells of a microtiter plate with 50 &#x000b5;L extraction buffer and 100 &#x000b5;L reaction mixture (300 mM Tris-HCl buffer pH 8.0, containing 12 mM EDTA, 0.6 mM MTT, 3 mM PMS and 45 U/mL LDH). The cycling reaction was started by the addition of 100 &#x000b5;L 0.5&#x000a0;M lactate (in water) to each well. The increase in absorbance of the MTT formazan generated was monitored at 570&#x000a0;nm for 10&#x000a0;min using the Multiskan Sky Microplate Spectrophotometer (Thermo Fisher Scientific, Bremen, Germany). The calibration curve created from the slopes of the linear increases in the absorbance over time recorded for the standards was used to calculate the amount of total cellular NAD(H) and of NADH in the non-heated and heated lysates, respectively. The cellular NAD<sup>+</sup> content was calculated by subtracting the cellular NADH content (heated lysate) from the total cellular NAD(H) content (not heated lysate). The specific NAD(H) content was calculated by normalising the cellular NAD(H) content per well to the initial cellular protein content of the respective culture.</p><p id="Par13">To quantify the cellular NADP(H) (sum of NADP<sup>+</sup> and NADPH) content, 100 &#x000b5;L of the heated alkaline lysate (for the quantification of NADPH), of the not heated lysates (for the quantification of NADPH plus NADP<sup>+</sup>) or of NADPH standards (0&#x02013;60 pmol/100 &#x000b5;L alkaline extraction buffer) were diluted with 100 &#x000b5;L reaction mixture (300 mM Tris-HCl buffer pH 8.0, 15 mM EDTA, 1.5 mM MTT, 3 mM PES, 30 U/mL glucose-6-phosphate dehydrogenase). The cycling reaction was started by the addition of 100 &#x000b5;L 3 mM glucose-6-phosphate (in water) to each well. The increase in absorbance of the MTT formazan generated was monitored at 570&#x000a0;nm for 10&#x000a0;min. NADP(H) was quantified by making use of the signals observed for NADPH standards as described above for the NAD(H) quantification.</p></sec><sec id="Sec8"><title>Determination of Extracellular Lactate</title><p id="Par14">The concentration of extracellular lactate that was produced and released from the cells during a given incubation was determined by a coupled enzymatic assay with LDH and glutamate-pyruvate transaminase in an alkaline glutamate buffer in microtiter plate format as previously described [<xref ref-type="bibr" rid="CR33">33</xref>]. The NADH generated from lactate in the assay was quantified by determining the increase in absorption at 340&#x000a0;nm and this value was used to calculate the extracellular concentration of lactate [<xref ref-type="bibr" rid="CR33">33</xref>].</p></sec><sec id="Sec9"><title>Determination of Cellular Protein Content and Cell Viability</title><p id="Par15">The initial cellular protein content per well was determined by the Lowry method [<xref ref-type="bibr" rid="CR38">38</xref>] using bovine serum albumin as standard protein. A potential loss of cell viability by a given treatment was tested for by measuring the extracellular activity of LDH (in 10 &#x000b5;L harvested media samples after a given incubation) and comparing this activity with the initial cellular LDH activity determined for Triton X-100 lysates (100% cellular LDH activity) of untreated cells. The extracellular LDH activity found after a given treatment was compared to the initial cellular LDH activity as previously described [<xref ref-type="bibr" rid="CR33">33</xref>].</p></sec><sec id="Sec10"><title>Data Presentation and Statistical Analysis</title><p id="Par16">The data shown in figures and tables represent means&#x02009;&#x000b1;&#x02009;standard deviations (SDs) of values obtained from n independent experiments that had been performed in duplicates on the given number of independently prepared astrocyte cultures. For data sets from less than 5 independent experiments, statistical analysis was done under the assumption of normal distribution. Analysis for statistical significance between groups of data was done by ANOVA (followed by the Bonferroni post-hoc test). Experiments showing time-dependencies of various treatments were analyzed by a two-way ANOVA for the factors treatment and incubation time. Differences between two groups of data were tested for statistical significance by the paired t-test. The calculated levels of significance compared to the respective control conditions are given in the figures and tables as described in the respective legends. <italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05 was considered as not significant.</p></sec></sec><sec id="Sec11" sec-type="results"><title>Results</title><sec id="Sec12"><title>Depletion of the Cellular ATP Content of Cultured Astrocytes by Glucose Deprivation and BAM15 Application</title><p id="Par17">To study ATP restoration of cultured astrocytes, the initial high cellular ATP content of such cultures was first lowered by a preincubation with the uncoupler BAM15 in glucose-free buffer as previously described [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Data obtained in a total of 30 experiments revealed that a 60&#x000a0;min incubation with 1 &#x000b5;M BAM15 lowered the initial cellular ATP content from an initial value of 32.2&#x02009;&#x000b1;&#x02009;4.7 nmol/mg by 80% to 6.7&#x02009;&#x000b1;&#x02009;2.7 nmol/mg, while no significant loss in cellular ATP content was observed for glucose-deprived astrocytes that had been incubation in the absence of the uncoupler (Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>). In contrast to the cellular ATP level, a 60&#x000a0;min glucose-free incubation without or with BAM15 did not cause large differences in the specific cellular contents of the nicotinamide coenzymes NAD<sup>+</sup>, NADH, NADP<sup>+</sup> and NADPH nor in the percental ratios of NADH/NAD(H) or NADPH/NADP(H). However, compared to the initial values some decline in the cellular contents of nicotinamide coenzymes was found for both incubation conditions (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) which is consistent with literature data and most likely caused by the absence of NAD<sup>+</sup> precursors during the incubation [<xref ref-type="bibr" rid="CR39">39</xref>]. None of the conditions applied caused any obvious damage of the cells as indicated by the absence of any substantial increase in extracellular LDH activity (Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par18">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>ATP content and cell viability of BAM15-treated cultured astrocytes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Treatment</th><th align="left" rowspan="2">Incubation time (min)</th><th align="left" colspan="2">ATP content</th><th align="left" rowspan="2">LDH release (%)</th></tr><tr><th align="left">(nmol/mg)</th><th align="left">(% of initial)</th></tr></thead><tbody><tr><td align="left">None</td><td align="left">0</td><td char="&#x000b1;" align="char">32.2&#x02009;&#x000b1;&#x02009;4.7</td><td char="&#x000b1;" align="char">100</td><td char="&#x000b1;" align="char">0</td></tr><tr><td align="left">Without BAM15</td><td align="left">60</td><td char="&#x000b1;" align="char">31.0&#x02009;&#x000b1;&#x02009;4.9</td><td char="&#x000b1;" align="char">97&#x02009;&#x000b1;&#x02009;13</td><td char="&#x000b1;" align="char">5&#x02009;&#x000b1;&#x02009;4</td></tr><tr><td align="left">With BAM15</td><td align="left">60</td><td char="&#x000b1;" align="char">6.7&#x02009;&#x000b1;&#x02009;2.7<sup>###</sup></td><td char="&#x000b1;" align="char">21&#x02009;&#x000b1;&#x02009;9<sup>###</sup></td><td char="&#x000b1;" align="char">4&#x02009;&#x000b1;&#x02009;1</td></tr></tbody></table><table-wrap-foot><p>The cells were incubated for 60&#x000a0;min in the absence or the presence of 1 &#x000b5;M of the uncoupler BAM15 before the cellular ATP content and the extracellular LDH activity (as indicator for a potential cell toxicity, given as % of total cellular LDH activity) were determined. The data presented are means&#x02009;&#x000b1;&#x02009;SD of values that were obtained in 30 (ATP) and 13 (LDH) experiments on 25 (ATP) and 13 (LDH) independently prepared cultures. The significance of differences (paired t-test) between data for incubations without and with BAM15 is indicated by <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001</p></table-wrap-foot></table-wrap>
</p><p id="Par19">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Metabolic parameters of BAM15-treated cultured astrocytes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Incubation time</th><th align="left">0&#x000a0;min</th><th align="left">60&#x000a0;min</th><th align="left">60&#x000a0;min</th></tr><tr><th align="left">Presence of BAM15</th><th align="left">no</th><th align="left">no</th><th align="left">yes</th></tr></thead><tbody><tr><td align="left">ATP content (nmol/mg)</td><td char="&#x000b1;" align="char">29.2&#x02009;&#x000b1;&#x02009;1.8</td><td char="&#x000b1;" align="char">29.6&#x02009;&#x000b1;&#x02009;4.1</td><td char="&#x000b1;" align="char">6.0&#x02009;&#x000b1;&#x02009;4.5***<sup>, ###</sup></td></tr><tr><td align="left">NAD(H) content (nmol/mg)</td><td char="&#x000b1;" align="char">2.74&#x02009;&#x000b1;&#x02009;0.14</td><td char="&#x000b1;" align="char">1.97&#x02009;&#x000b1;&#x02009;0.20**</td><td char="&#x000b1;" align="char">1.91&#x02009;&#x000b1;&#x02009;0.33**</td></tr><tr><td align="left">NAD<sup>+</sup> content (nmol/mg)</td><td char="&#x000b1;" align="char">1.66&#x02009;&#x000b1;&#x02009;0.07</td><td char="&#x000b1;" align="char">1.49&#x02009;&#x000b1;&#x02009;0.16</td><td char="&#x000b1;" align="char">1.54&#x02009;&#x000b1;&#x02009;0.25</td></tr><tr><td align="left">NADH content (nmol/mg)</td><td char="&#x000b1;" align="char">1.08&#x02009;&#x000b1;&#x02009;0.16</td><td char="&#x000b1;" align="char">0.48&#x02009;&#x000b1;&#x02009;0.20*</td><td char="&#x000b1;" align="char">0.37&#x02009;&#x000b1;&#x02009;0.18**<sup>, ##</sup></td></tr><tr><td align="left">NADH content (% of NAD(H))</td><td char="&#x000b1;" align="char">39&#x02009;&#x000b1;&#x02009;4</td><td char="&#x000b1;" align="char">24&#x02009;&#x000b1;&#x02009;8</td><td char="&#x000b1;" align="char">19&#x02009;&#x000b1;&#x02009;7*<sup>, #</sup></td></tr><tr><td align="left">NADP(H) content (nmol/mg)</td><td char="&#x000b1;" align="char">0.61&#x02009;&#x000b1;&#x02009;0.03</td><td char="&#x000b1;" align="char">0.52&#x02009;&#x000b1;&#x02009;0.05</td><td char="&#x000b1;" align="char">0.47&#x02009;&#x000b1;&#x02009;0.03**</td></tr><tr><td align="left">NADP<sup>+</sup> content (nmol/mg)</td><td char="&#x000b1;" align="char">0.34&#x02009;&#x000b1;&#x02009;0.14</td><td char="&#x000b1;" align="char">0.32&#x02009;&#x000b1;&#x02009;0.06</td><td char="&#x000b1;" align="char">0.35&#x02009;&#x000b1;&#x02009;0.03</td></tr><tr><td align="left">NADPH content (nmol/mg)</td><td char="&#x000b1;" align="char">0.27&#x02009;&#x000b1;&#x02009;0.14</td><td char="&#x000b1;" align="char">0.20&#x02009;&#x000b1;&#x02009;0.07</td><td char="&#x000b1;" align="char">0.12&#x02009;&#x000b1;&#x02009;0.05<sup>#</sup></td></tr><tr><td align="left">NADPH content (% of NADP(H))</td><td char="&#x000b1;" align="char">44&#x02009;&#x000b1;&#x02009;22</td><td char="&#x000b1;" align="char">38&#x02009;&#x000b1;&#x02009;12</td><td char="&#x000b1;" align="char">26&#x02009;&#x000b1;&#x02009;10<sup>##</sup></td></tr><tr><td align="left">Extracellular LDH activity (%)</td><td char="&#x000b1;" align="char">0</td><td char="&#x000b1;" align="char">2&#x02009;&#x000b1;&#x02009;4</td><td char="&#x000b1;" align="char">4&#x02009;&#x000b1;&#x02009;2</td></tr></tbody></table><table-wrap-foot><p>The cells were incubated without glucose for 60&#x000a0;min in the absence or the presence of 1 &#x000b5;M of the uncoupler BAM15. The given cellular metabolic parameters of the cultures were determined before (0&#x000a0;min, untreated cells) and after the 60&#x000a0;min incubation. NAD(H) represents the sum of NAD<sup>+</sup> plus NADH, while NADP(H) represents the sum of NADP<sup>+</sup> plus NADPH. The extracellular LDH activity (given as % of the initial cellular LDH activity) was measured after the 60&#x000a0;min incubation as indicator for potential cell toxicity. The data presented are means&#x02009;&#x000b1;&#x02009;SD of values that were obtained in experiments on three independently prepared cultures. The initial cellular LDH activity was 192&#x02009;&#x000b1;&#x02009;20 nmol/(min x well) and the initial cellular protein content was 158&#x02009;&#x000b1;&#x02009;11&#x000a0;&#x000b5;g/well. The significance of differences (ANOVA) compared to the initial values of untreated cells is indicated by asterisks (*<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) and that between data for incubations without and with BAM15 (paired t-test) is indicated by hashes (<sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001)</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec13"><title>Restoration of the Cellular ATP Content of Astrocytes in the Presence of Energy Substrates and/or Adenosine</title><p id="Par20">To test for the potential of BAM15-treated ATP-depleted astrocytes to restore their cellular ATP content after removal of the uncoupler, the cells were washed and incubated in amino acid-free IB in the absence or the presence of 5 mM glucose. During a 6&#x000a0;h incubation in glucose-free IB, the low ATP content determined for BAM15-treated astrocytes (around 25% of the initial cellular ATP content) remained stable for up to 2&#x000a0;h (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>), but decreased further to around 10% of the initial ATP content during longer incubations for up to 6&#x000a0;h (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). In contrast, the cellular ATP content of glucose-fed cells increased during incubations for 60&#x000a0;min and 6&#x000a0;h to amounts that accounted for around 50% and 80%, respectively, of the initial cellular ATP content of untreated cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). If glucose was substituted by pyruvate, the cellular ATP restoration was less efficient although the cellular ATP content was found significantly increased and around half of the cellular ATP that had been lost during the BAM15 treatment was restored within 6&#x000a0;h (Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a and <xref rid="Fig2" ref-type="fig">2</xref>a). Partial ATP restoration by ATP-depleted astrocytes was also observed for a treatment with lactate, but not for 6&#x000a0;h incubations with acetate or &#x003b2;-hydroxybutyrate (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a).</p><p id="Par21">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Time-dependency of the ATP restoration by ATP-deprived cultured astrocytes. The cells had been preincubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 to lower the cellular ATP content before the cells were incubated without (none) or with 5 mM glucose or 5 mM pyruvate in the absence (<bold>a</bold>, <bold>c</bold>) or the presence (<bold>b</bold>, <bold>c</bold>) of 1 mM adenosine. The cellular ATP content was determined for the given incubation periods (<bold>a</bold>, <bold>b</bold>) and the extracellular LDH activity for the 360&#x000a0;min incubation (<bold>c</bold>). The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in three experiments performed on independently prepared cultures. The average initial ATP content of the cultures was 31.7&#x02009;&#x000b1;&#x02009;0.6 nmol/mg as indicated by the black dotted lines in panels a and b. The initial cellular LDH activity was 103&#x02009;&#x000b1;&#x02009;5 nmol/(min x well) and the initial cellular protein content was 113&#x02009;&#x000b1;&#x02009;1&#x000a0;&#x000b5;g/well. The significance of differences (ANOVA) of data compared to the respective glucose- and pyruvate-free control condition (none) is indicated by *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 in the colors of the respective conditions. The significance of differences (paired t-test) between data for incubations without (<bold>a</bold>) and with (<bold>b</bold>) adenosine are indicated by hashes in panel b with <sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. Two-way ANOVA revealed that the time of the main incubation (no adenosine: F&#x02009;=&#x02009;5.27, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; adenosine: F&#x02009;=&#x02009;67.49, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) as well as the kind of treatment (no adenosine: F&#x02009;=&#x02009;17.97, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; adenosine: F&#x02009;=&#x02009;12.9, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) have highly significant effects on the ATP restoration</p></caption><graphic xlink:href="11064_2024_4276_Fig1_HTML" id="d33e872"/></fig>
</p><p id="Par22">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>ATP restoration after application of glucose and/or adenosine in BAM15-treated cultured astrocytes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Condition</th><th align="left" colspan="2">ATP content</th><th align="left" rowspan="2">Number of experiments (independent cultures)</th></tr><tr><th align="left">(nmol/mg)</th><th align="left">(% of initial)</th></tr></thead><tbody><tr><td align="left">Untreated cells</td><td char="&#x000b1;" align="char">32.8&#x02009;&#x000b1;&#x02009;6.0</td><td char="&#x000b1;" align="char">100</td><td align="left">17 (13)</td></tr><tr><td align="left">BAM15-preincubated cells</td><td char="&#x000b1;" align="char">7.6&#x02009;&#x000b1;&#x02009;3.3</td><td char="&#x000b1;" align="char">23&#x02009;&#x000b1;&#x02009;9</td><td align="left">17 (13)</td></tr><tr><td align="left" colspan="4">
<bold>60&#x000a0;min main incubation</bold>
</td></tr><tr><td align="left">No substrate</td><td char="&#x000b1;" align="char">10.0&#x02009;&#x000b1;&#x02009;3.3***</td><td char="&#x000b1;" align="char">30&#x02009;&#x000b1;&#x02009;8***</td><td align="left">15 (12)</td></tr><tr><td align="left">Glucose</td><td char="&#x000b1;" align="char">16.4&#x02009;&#x000b1;&#x02009;5.6***<sup>, ##</sup></td><td char="&#x000b1;" align="char">49&#x02009;&#x000b1;&#x02009;13***<sup>, #</sup></td><td align="left">14 (13)</td></tr><tr><td align="left">Adenosine</td><td char="&#x000b1;" align="char">25.7&#x02009;&#x000b1;&#x02009;6.9*<sup>, ###</sup></td><td char="&#x000b1;" align="char">78&#x02009;&#x000b1;&#x02009;13***<sup>, ###</sup></td><td align="left">17 (13)</td></tr><tr><td align="left">Glucose&#x02009;+&#x02009;adenosine</td><td char="&#x000b1;" align="char">31.4&#x02009;&#x000b1;&#x02009;9.0 <sup>###</sup></td><td char="&#x000b1;" align="char">94&#x02009;&#x000b1;&#x02009;13 <sup>###</sup></td><td align="left">13 (12)</td></tr><tr><td align="left" colspan="4">
<bold>360&#x000a0;min main incubation</bold>
</td></tr><tr><td align="left">No substrate</td><td char="&#x000b1;" align="char">3.3&#x02009;&#x000b1;&#x02009;1.7***</td><td char="&#x000b1;" align="char">8&#x02009;&#x000b1;&#x02009;5***</td><td align="left">12 (12)</td></tr><tr><td align="left">Glucose</td><td char="&#x000b1;" align="char">27.6&#x02009;&#x000b1;&#x02009;9.0 <sup>###</sup></td><td char="&#x000b1;" align="char">80&#x02009;&#x000b1;&#x02009;11***<sup>, ###</sup></td><td align="left">12 (12)</td></tr><tr><td align="left">Adenosine</td><td char="&#x000b1;" align="char">17.6&#x02009;&#x000b1;&#x02009;4.8***<sup>, ###</sup></td><td char="&#x000b1;" align="char">54&#x02009;&#x000b1;&#x02009;15***<sup>, #</sup></td><td align="left">12 (12)</td></tr><tr><td align="left">Glucose&#x02009;+&#x02009;adenosine</td><td char="&#x000b1;" align="char">34.0&#x02009;&#x000b1;&#x02009;14.1<sup>###</sup></td><td char="&#x000b1;" align="char">102&#x02009;&#x000b1;&#x02009;19 <sup>###</sup></td><td align="left">9 (9)</td></tr></tbody></table><table-wrap-foot><p>The cells had been preincubated for 60&#x000a0;min in the presence of 1 &#x000b5;M of the uncoupler BAM15 to deplete astrocytes of ATP and were subsequently exposed for 60 or360&#x000a0;min in the absence or the presence of 5 mM glucose and/or 1 mM adenosine before the cellular ATP content was determined. The data presented are means&#x02009;&#x000b1;&#x02009;SD of values that were obtained in n experiments on the given number (in brackets) of independently prepared cultures. The significance of differences (ANOVA) compared to the initial ATP content (given as asterisks) and to the ATP content determined after the BAM15 treatment (given as hashes) are indicated by *<sup>, #</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<sup>, ###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. Two-way ANOVA revealed that the time of the main incubation (F&#x02009;=&#x02009;54.91, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) and the kind of treatment (F&#x02009;=&#x02009;27.33, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) have highly significant effects on the ATP restoration</p></table-wrap-foot></table-wrap>
</p><p id="Par23">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Use of various energy substrates for ATP restoration by ATP-deprived astrocytes. Astrocyte cultures had been preincubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 to lower the cellular ATP content before the cells were incubated in glucose-free IB that had been supplemented with 5 mM of the given energy substrates. After 60 or360&#x000a0;min, the cellular ATP content (<bold>a</bold>) and after 360&#x000a0;min the extracellular LDH activity (<bold>b</bold>) were determined. The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in six experiments performed on independently prepared cultures. The average initial ATP content of the cultures (37.9&#x02009;&#x000b1;&#x02009;5.2 nmol/mg) is indicated by the black dotted line in panel a and the ATP content determined for the 60&#x000a0;min BAM15 preincubation (10.4&#x02009;&#x000b1;&#x02009;2.6 nmol/mg) is indicated by the black dashed line in panel a. The cultures contained 144&#x02009;&#x000b1;&#x02009;21&#x000a0;&#x000b5;g protein/well and an initial cellular LDH activity of 177&#x02009;&#x000b1;&#x02009;62 nmol/(min &#x000d7; well). The significance of differences (ANOVA) compared with the data obtained for the respective control incubation (none, absence of any exogenous substrates) is indicated by *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. The significance of differences (t-test) between the data obtained for the 1&#x000a0;h and 6&#x000a0;h incubation of a given condition is indicated by <sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. glc, glucose; lac, lactate; pyr, pyruvate; ace, acetate; bHB, &#x003b2;-hydroxybutyrate</p></caption><graphic xlink:href="11064_2024_4276_Fig2_HTML" id="d33e1086"/></fig>
</p><p id="Par24">The slow and partial ATP restoration observed in ATP-deprived astrocytes after application of glucose (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a) was strongly accelerated by coapplication of 1 mM adenosine as precursor for the purine moiety of ATP (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>) and the initial cellular ATP content was found fully reestablished already within 60&#x000a0;min (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). However, also the application of adenosine alone in glucose-free IB enabled BAM15-preincubated astrocytes to restore within 60&#x000a0;min around 80% of their initial ATP content (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). This adenosine-mediated increase was transient and the cellular ATP content was found lowered after longer incubations for 6&#x000a0;h in glucose-free IB (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). However, the decline in ATP content of adenosine-treated cells during longer incubations was prevented by the presence of glucose or pyruvate as energy substrates (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). None of the conditions applied caused any obvious cell toxicity as demonstrated by the low extracellular LDH activity found after incubations for 360&#x000a0;min (Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c and <xref rid="Fig2" ref-type="fig">2</xref>b).</p></sec><sec id="Sec14"><title>Effects of a BAM15-Treatment and -Removal on the Cellular Contents of ATP, ADP and AMP in Astrocytes</title><p id="Par25">During the 60&#x000a0;min incubation of astrocytes in glucose-free IB with BAM15, the cellular ATP content had declined from 30.1&#x02009;&#x000b1;&#x02009;6.5 nmol/mg to 8.0&#x02009;&#x000b1;&#x02009;7.2 nmol/mg, while the cellular contents of ADP and AMP were found increased from 1.5&#x02009;&#x000b1;&#x02009;0.8 nmol/mg to 6.0&#x02009;&#x000b1;&#x02009;0.4 nmol/mg and unaltered (2.4&#x02009;&#x000b1;&#x02009;2.7 nmol/mg and 2.7&#x02009;&#x000b1;&#x02009;0.6 nmol/mg), respectively (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). In addition, the sum of the three adenosine phosphates had declined after the BAM15-treatment from 35.2&#x02009;&#x000b1;&#x02009;6.6 nmol/mg to 16.7&#x02009;&#x000b1;&#x02009;1.2 nmol/mg and the AEC from 0.92&#x02009;&#x000b1;&#x02009;0.04 to 0.65&#x02009;&#x000b1;&#x02009;0.04 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Removal of the uncoupler caused for all incubation conditions a rapid initial increase in ATP content by up to 8 nmol/mg (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a) that was accompanied by a decline in the cellular contents of ADP and AMP (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b, c), which is likely to be the consequence of rapid phosphorylation of ADP and AMP to ATP after application of substrates. Although this process did hardly affect the sum of adenosine phosphates (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>e), the high AEC was almost fully reestablished within 5&#x000a0;min of incubation in the presence of substrates (glucose and/or adenosine) and also within 30&#x000a0;min in substrate-free buffer (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d). During longer incubations, the cellular ATP contents were restored (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a) to the extents previously determined for the different incubation conditions applied (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>), while the specific cellular contents of ADP (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b) and AMP (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c) as well as the AEC (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d) did not differ anymore from the respective values of untreated cells. Only for BAM15-pretreated astrocytes that had been incubated without substrates for 6&#x000a0;h the ATP content (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a) and the sum of adenosine phosphates (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>e) were found lowered compared to the data found for cells directly after the BAM15-exposure and the calculated AEC (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d) was similarly low for this condition. None of the conditions applied caused any obvious cell toxicity as demonstrated by the low extracellular LDH activity (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>f).</p><p id="Par26">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Alterations in cellular adenosine phosphate contents during ATP restoration in ATP-deprived cultured astrocytes. The cells had been preincubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 before the cells were incubated without (none) or with 5 mM glucose and/or 1 mM adenosine for up to 360&#x000a0;min. The cellular specific contents of ATP (<bold>a</bold>), ADP (<bold>b</bold>) and AMP (<bold>c</bold>) were determined for the given incubation periods and the extracellular LDH activity for the 360&#x000a0;min incubation (<bold>f</bold>). In addition, the AEC (<bold>d</bold>) and the sum of adenosine phosphates (<bold>e</bold>) were calculated. The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in three experiments performed on independently prepared cultures. The average initial values determined for untreated cultures (30.1&#x02009;&#x000b1;&#x02009;6.5 nmol ATP/mg; 1.5&#x02009;&#x000b1;&#x02009;0.8 nmol ADP/mg; 2.4&#x02009;&#x000b1;&#x02009;2.7 nmol AMP/mg; AEC: 0.92&#x02009;&#x000b1;&#x02009;0.04; sum of adenosine phosphates: 35.2&#x02009;&#x000b1;&#x02009;6.6 nmol/mg) are indicated by the black dotted lines. The initial cellular LDH activity was 110&#x02009;&#x000b1;&#x02009;28 nmol/(min x well) and the initial cellular protein content was 99&#x02009;&#x000b1;&#x02009;23&#x000a0;&#x000b5;g/well. The significance of differences (ANOVA) of data compared to the values determined after the 60&#x000a0;min preincubation (0&#x000a0;min on x-axis) is indicated by *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 in the colors of the respective conditions. The significance of differences (ANOVA) of data compared to the control condition (none) is indicated by <sup>+</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>++</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>+++</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 in the colors of the respective conditions. Two way ANOVA revealed that the time of the main incubation (ATP: F&#x02009;=&#x02009;12.69, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; AEC: F&#x02009;=&#x02009;37.14, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; sum of adenylates: F&#x02009;=&#x02009;5.58, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) as well as the kind of treatment (ATP: F&#x02009;=&#x02009;20.63, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; AEC: F&#x02009;=&#x02009;14.26, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; sum of adenylates: F&#x02009;=&#x02009;14.68, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) have highly significant effects on the ATP restoration, the AEC and the sum of adenylates. The cellular contents of ADP and AMP were significantly affected by the time of main incubation (ADP: F&#x02009;=&#x02009;14.78, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; AMP: F&#x02009;=&#x02009;12.81, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), but not by the kind of treatment (ADP: F&#x02009;=&#x02009;1.99, <italic>p</italic>&#x02009;=&#x02009;0.125; AMP: F&#x02009;=&#x02009;1.9, <italic>p</italic>&#x02009;=&#x02009;0.139). glc, glucose; ade, adenosine</p></caption><graphic xlink:href="11064_2024_4276_Fig3_HTML" id="d33e1267"/></fig>
</p></sec><sec id="Sec15"><title>Test for the Involvement of Mitochondrial Processes in the ATP Restoration by ATP-Deprived Astrocytes</title><p id="Par27">To test for a potential contribution of mitochondrial metabolisms in ATP restoration during incubations with adenosine and/or glucose, BAM15-treated astrocytes were incubated for 60&#x000a0;min without or with 5 mM glucose and/or 1 mM adenosine in the absence or the presence of UK5099, an inhibitor of the mitochondrial pyruvate carrier [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>], antimycin A, an inhibitor of complex III of the respiratory chain [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], or with the uncoupler BAM15 [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. An adenosine concentration of 1 mM was chosen for this type of experiment to enable the cells to produce in the absence of glucose reasonable amounts of lactate from the nucleoside as exclusive exogenous substrate.</p><p id="Par28">Compared to the inhibitor-free control condition (none), all three modulators of mitochondrial metabolism prevented the adenosine-induced ATP restoration in the absence of glucose (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a), but not in the presence of glucose (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). In addition, the three inhibitors hardly affected the lactate release from glucose-treated astrocytes under the conditions used (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d), while the low amounts of lactate released from astrocytes that had been incubated without glucose in the absence or the presence of adenosine were strongly increased by the inhibitors of mitochondrial processes (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). None of the conditions applied caused any obvious damage of the cells as indicated by the absence of any increase in extracellular LDH activity (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>e, f).</p><p id="Par29">
<fig id="Fig4"><label>Fig. 4</label><caption><p>Effects of mitochondrial inhibitors on ATP restoration and lactate release by ATP-deprived astrocytes. The cultures had been preincubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 to lower the cellular ATP content before the cells were incubated in the absence (<bold>a</bold>, <bold>c</bold>, <bold>e</bold>) or the presence (<bold>b</bold>, <bold>d</bold>, <bold>f</bold>) of 5 mM glucose without or with 1 mM adenosine. For these conditions, the cells were coincubated without (none) or with an inhibitor of the mitochondrial pyruvate carrier (UK5099, UK; 10 &#x000b5;M) or of the complex III of the respiratory chain (antimycin A, Anti; 1 &#x000b5;M) or with BAM15 (BAM; 1 &#x000b5;M). After a 60&#x000a0;min main incubation, the cellular ATP content (<bold>a</bold>, <bold>b</bold>), the extracellular lactate accumulation (<bold>c</bold>, <bold>d</bold>) and the extracellular LDH activity (<bold>e</bold>, <bold>f</bold>) were determined. The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in three experiments performed on independently prepared cultures. The average initial ATP content of the cultures (32.0&#x02009;&#x000b1;&#x02009;5.7 nmol/mg) is indicated by the black dotted lines in panels a and b. The protein content of the cultures was 141&#x02009;&#x000b1;&#x02009;23&#x000a0;&#x000b5;g/well and the initial cellular LDH activity 163&#x02009;&#x000b1;&#x02009;11 nmol/(min &#x000d7; well). The significance of differences (ANOVA) compared with the data obtained for the respective control incubation (none) is indicated by *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. The significance of differences (ANOVA) compared with the ATP data obtained for the 60&#x000a0;min preincubation (7.6&#x02009;&#x000b1;&#x02009;3.1 nmol/mg; indicated by the black dashed lines in panels a and b) is indicated by <sup>+</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and <sup>++</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01. The significance of differences (t-test) between data obtained for adenosine-free and adenosine-containing incubations is indicated by <sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001</p></caption><graphic xlink:href="11064_2024_4276_Fig4_HTML" id="d33e1395"/></fig>
</p></sec><sec id="Sec16"><title>Concentration Dependency of the Adenosine-Dependent ATP Restoration in ATP-Depleted Astrocytes</title><p id="Par30">The presence of adenosine in a concentration of 1 mM allowed ATP-depleted astrocytes to restore within 60&#x000a0;min the cellular ATP content to around 80% in the absence of glucose and to more than 90% in the presence of glucose (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The observed ATP restoration depended strongly on the concentration of adenosine applied (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). In the absence of glucose significant ATP restoration was observed for incubations of BAM15-treated astrocytes with 30 &#x000b5;M adenosine but even higher concentrations of up to 1 mM adenosine did not allow the cells to fully restore their initial ATP content (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). In contrast, much lower concentrations of adenosine were required to efficiently increase the ATP content in glucose-treated BAM15-preincubated astrocytes (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). For such conditions, already adenosine in concentrations of 10 &#x000b5;M and 30 &#x000b5;M allowed half-maximal and maximal ATP restoration (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). For adenosine concentrations of up to 100 &#x000b5;M the coincubation with glucose increased the cellular ATP content determined after the restoration period by around 10 nmol/mg (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). None of the conditions applied caused any obvious cell damage as indicated by the absence of any increase in extracellular LDH activity (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b).</p><p id="Par31">
<fig id="Fig5"><label>Fig. 5</label><caption><p>Adenosine dependent ATP restoration by astrocytes. The cells had been pre-incubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 to lower the cellular ATP content before the cells were incubated without or with 5 mM glucose in the presence of the indicated concentrations of adenosine. After 60&#x000a0;min, the cellular ATP content (<bold>a</bold>) and the extracellular LDH activity (<bold>b</bold>) were determined. The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in three experiments performed on independently prepared cultures. The average initial ATP content of the cultures (32.0&#x02009;&#x000b1;&#x02009;5.7 nmol/mg) is indicated by the black dotted lines in panel a. The cellular protein content was 141&#x02009;&#x000b1;&#x02009;23&#x000a0;&#x000b5;g/well and the initial cellular LDH activity 163&#x02009;&#x000b1;&#x02009;11 nmol/(min &#x000d7; well). The significance of differences (ANOVA) compared with the data obtained for the control incubation (absence of glucose and adenosine) is indicated by *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. The significance of differences (ANOVA) compared with the data obtained for the 60&#x000a0;min preincubation (7.6&#x02009;&#x000b1;&#x02009;3.1 nmol/mg; indicated by the black dashed lines in panel a) is indicated by <sup>+</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>++</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and <sup>+++</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. The significance of differences (t-test) between data obtained for glucose-free and glucose-containing incubations is indicated by <sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05</p></caption><graphic xlink:href="11064_2024_4276_Fig5_HTML" id="d33e1464"/></fig>
</p></sec><sec id="Sec17"><title>Test for the Consequences of an Impairment of Adenosine Metabolism on the Adenosine-Dependent ATP Restoration by ATP-Deprived Astrocytes</title><p id="Par32">To test how the modulation of cellular adenosine metabolism may affect the ability of adenosine to serve as exogenous substrate for ATP restoration, BAM15-treated astrocytes were incubated in glucose-containing buffer without or with 30 &#x000b5;M adenosine. An adenosine concentration of 30 &#x000b5;M was chosen for this type of experiment as this concentration was found to enabled the cells in the presence of glucose to fully restore the initial ATP content within 60&#x000a0;min (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a).</p><p id="Par33">For those conditions, the cells were able to restore within 60 min 50% (glucose) and 80% (glucose plus adenosine) of their initial ATP content (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a). The adenosine-induced acceleration of the ATP restoration was completely prevented by the presence of the adenosine kinase inhibitor ABT-702 (10 &#x000b5;M) [<xref ref-type="bibr" rid="CR46">46</xref>], while the presence of the adenosine deaminase inhibitor DCF (2&#x02019;-deoxycoformycin) (1 &#x000b5;M) [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] and/or of the purine nucleoside phosphorylase inhibitor forodesine (10 &#x000b5;M) [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] nor their combinations compromised ATP restoration under the conditions used (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a). None of the inhibitors nor their combinations affected the glucose-dependent partial ATP restoration in the absence of adenosine (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>a) nor the cell viability for any of the conditions investigated (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>b).</p><p id="Par34">
<fig id="Fig6"><label>Fig. 6</label><caption><p>Effects of inhibitors of adenosine metabolism on the utilization of adenosine for ATP restoration in glucose-fed astrocytes. Astrocyte cultures had been preincubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 to lower the cellular ATP content before the cells were incubated in glucose (5 mM)-containing IB without or with 30 &#x000b5;M adenosine in the absence or the presence of the adenosine kinase inhibitor ABT-702 (ABT; 10 &#x000b5;M), the adenosine deaminase inhibitor DCF (1 &#x000b5;M) and/or the purine nucleoside phosphorylase inhibitor forodesine (Foro; 10 &#x000b5;M). After 60&#x000a0;min, the cellular ATP content (<bold>a</bold>) and the extracellular LDH activity (<bold>b</bold>) were determined. The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in three experiments performed on independently prepared cultures. The average initial ATP content of the cultures (36.8&#x02009;&#x000b1;&#x02009;1.6 nmol/mg) is indicated by the black dotted line in panel a. The protein content of the cultures was 130&#x02009;&#x000b1;&#x02009;12&#x000a0;&#x000b5;g/well and the initial cellular LDH activity 119&#x02009;&#x000b1;&#x02009;5 nmol/(min &#x000d7; well). The significance of differences (ANOVA) compared with the data obtained for the respective control incubation (absence of all inhibitors) is indicated by ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. The significance of differences (t-test) between data for adenosine-free and the respective adenosine-containing incubations is indicated by <sup>#</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01and <sup>###</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001</p></caption><graphic xlink:href="11064_2024_4276_Fig6_HTML" id="d33e1534"/></fig>
</p><p id="Par35">To test how the inhibition of enzymes of the cellular adenosine metabolism may affect the ability of adenosine to serve as exclusive exogenous substrate for ATP restoration, BAM15-treated astrocytes were incubated in glucose-free buffer with 100 &#x000b5;M adenosine. This adenosine concentration was chosen for this type of experiment as the presence of 100 &#x000b5;M of the nucleoside was found to enable the cells to restore in the absence of glucose already half of the initial ATP content within 60&#x000a0;min (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a).</p><p id="Par36">For those conditions, the cells were able to restore within 60&#x000a0;min around 60% of the initial ATP content (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>a). This adenosine-dependent ATP restoration was significantly lowered by the presence of the adenosine kinase inhibitor ABT-702, the adenosine deaminase inhibitor DCF or the purine nucleoside phosphorylase inhibitor forodesine, while combinations of the inhibitors had little additive inhibitory effect on the ATP restoration compared to the potential of the single inhibitors to lower ATP restoration (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>a). None of the inhibitors nor their combinations affected the cell viability for any of the conditions investigated (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>b).</p><p id="Par37">
<fig id="Fig7"><label>Fig. 7</label><caption><p>Prevention of the exclusive utilization of adenosine for ATP restoration by inhibitors of adenosine metabolism. Astrocyte cultures had been preincubated for 60&#x000a0;min in glucose-free IB with 1 &#x000b5;M of BAM15 to lower the cellular ATP content before the cells were incubated in glucose-free IB with 100 &#x000b5;M adenosine in the absence or the presence of the adenosine kinase inhibitor ABT-702 (ABT; 10 &#x000b5;M), the adenosine deaminase inhibitor DCF (1 &#x000b5;M) and/or the purine nucleoside phosphorylase inhibitor forodesine (Foro; 10 &#x000b5;M). After 60&#x000a0;min, the cellular ATP content (<bold>a</bold>) and the extracellular LDH activity (<bold>b</bold>) were determined. The data shown are means&#x02009;&#x000b1;&#x02009;SD of values obtained in three experiments performed on independently prepared cultures. The average initial ATP content of the cultures (37.3&#x02009;&#x000b1;&#x02009;2.4 nmol/mg) is indicated by the black dotted line in panel a. The protein content of the cultures was 136&#x02009;&#x000b1;&#x02009;22&#x000a0;&#x000b5;g/well and the initial cellular LDH activity was 163&#x02009;&#x000b1;&#x02009;59 nmol/(min &#x000d7; well). The significance of differences (ANOVA) compared with the data obtained for the control incubation (absence of all inhibitors) is indicated by ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. The significance of differences (ANOVA) compared with the data obtained after the 60&#x000a0;min pre-incubation (8.1&#x02009;&#x000b1;&#x02009;4.4 nmol/mg; indicated by the black dashed lines in panel a) is indicated by <sup>+</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 and <sup>+++</sup><italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001</p></caption><graphic xlink:href="11064_2024_4276_Fig7_HTML" id="d33e1579"/></fig>
</p></sec></sec><sec id="Sec18" sec-type="discussion"><title>Discussion</title><p id="Par38">Cultured astrocytes contain a high cellular ATP content of around 30 nmol/mg that corresponds to a cytosolic ATP concentration of around 7 mM [<xref ref-type="bibr" rid="CR12">12</xref>]. This high ATP content is maintained in astrocytes by glycolytic and mitochondrial ATP regeneration from ADP [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] by making use of the energy obtained during the catabolism of glucose and other substrates [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In order to study ATP restoration, cultured astrocytes were first depleted of a substantial part of their cellular ATP by a 60&#x000a0;min preincubation with the mitochondrial uncoupler BAM15 in the absence of glucose. Such a treatment lowered the cellular ATP content within 60&#x000a0;min by around 75% without compromising cell viability, consistent with recent literature data [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Compared with this BAM15 treatment, other inhibitors of mitochondrial oxidative phosphorylation such as rotenone, antimycin A or oligomycin are known to deplete cultured astrocytes of ATP even faster and more efficiently [<xref ref-type="bibr" rid="CR18">18</xref>]. Reason for the lower potential of BAM15 to rapidly deplete cultured astrocytes of ATP compared to inhibitors of respiratory chain complexes [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] may be a residual ADP phosphorylation by ATP synthase in the presence of a rather low proton gradient that may be established by mitochondrial respiration even in the presence of the uncoupler.</p><p id="Par39">The BAM15 exposure was chosen as experimental paradigm as this treatment did not completely deplete astrocytes of their ATP leaving still a millimolar concentration of ATP in the cells which should be sufficient to enable rapid phosphorylation of substrates that will be applied to fuel ATP restoration. In addition, as the BAM15-treatment did not severely affect cellular levels or ratios of the nicotinamide coenzymes, a potential impairment of important oxidoreductase reactions has not to be considered for the restoration period. Finally, the observed rapid and complete restoration of ATP in BAM15-exposed astrocytes in the presence of suitable mitochondrial substrates demonstrates that the uncoupler was efficiently removed by the washing steps to allow ATP restoration. This was not the case for astrocytes that had been deprived of ATP by treatments with the complex I inhibitor rotenone [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], the complex III inhibitor antimycin A [<xref ref-type="bibr" rid="CR43">43</xref>] or the ATP synthase inhibitor oligomycin [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] (data not shown), most likely due to insufficient removal of the inhibitors by the washing steps performed before the restoration medium was applied.</p><p id="Par40">The observed loss in the cellular ATP content of BAM15-treated astrocytes was accompanied by a small increase in the cellular levels of ADP and AMP. Similar data have recently been reported for astrocytes that had been incubated with antimycin A either in the absence of glucose or in the presence of 2-deoxyglucose [<xref ref-type="bibr" rid="CR14">14</xref>]. A rapid cellular accumulation of ADP in starved and BAM15-treated astrocytes was expected as consequence of an impaired ADP phosphorylation by inhibition of both glycolysis and oxidative phosphorylation. As a further consequence the accumulated ADP will be used as substrate of adenylate kinase [<xref ref-type="bibr" rid="CR55">55</xref>], which phosphorylates one ADP molecule by phosphate transfer from a second ADP molecule [<xref ref-type="bibr" rid="CR56">56</xref>], thereby causing the increase in cellular AMP content. The observed increases in ADP and AMP contents as well as the decline in ATP content led to a reduction in the AEC from 0.9 to 0.6, as recently also reported for starved antimycin A-treated astrocytes [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par41">The 60&#x000a0;min exposure to BAM15 lowered severely the total amount of the three adenosine phosphates (sum of ATP, ADP and AMP), similar to results reported for starved cultured astrocytes [<xref ref-type="bibr" rid="CR14">14</xref>]. For brain slices, a similar loss in the total cellular adenosine phosphate pool was observed for various treatments [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>] and discussed to be the consequence of metabolic degradation of accumulated cellular AMP by dephosphorylation to adenosine, subsequent deamination to inosine [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] and final break down to non-salvageable purines [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. The metabolic elimination of AMP may contribute to the regulation of the cellular concentration of accumulated AMP in starved cells [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR58">58</xref>] and thereby to the regulation of the activation of AMP-mediated signaling processes [<xref ref-type="bibr" rid="CR63">63</xref>&#x02013;<xref ref-type="bibr" rid="CR65">65</xref>].</p><p id="Par42">Removal of BAM15 and subsequent incubation of the cells with glucose caused within 5&#x000a0;min a rapid increase in cellular ATP content by around 8 nmol/mg, which matched the concomitant rapid loss in the cellular contents of AMP and ADP. This suggests that the accumulated ADP and AMP contents in BAM15-treated astrocytes are rapidly phosphorylated within minutes after removal of the uncoupler and application of glucose, thereby reestablishing the high initial AEC of the cells. Glycolytic glucose metabolism is likely to fuel the rapid ADP phosphorylation after glucose application and cytosolic adenylate kinase will phosphorylate AMP to ADP [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. During longer restoration periods the reestablished low cellular contents of ADP and AMP as well as the high AEC initially found for untreated astrocytes [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>] were maintained for hours.</p><p id="Par43">After 60&#x000a0;min treatment with BAM15 in the absence of glucose, cultured astrocytes had lost around 50% of the initial sum of all adenosine phosphates which mainly represented loss of ATP. The lowered ATP content found after the BAM15-preincubation was maintained even in the absence of any exogenous substrates for at least 60&#x000a0;min, suggesting that the cells contained after the BAM15-treatment some intracellular substrates that help to prevent a further decline in cellular ATP content during the initial hour of the restoration phase. Most likely mitochondrial ATP regeneration is involved in this maintenance as the already low ATP content declined further in presence of mitochondrial inhibitors such as antimycin A or BAM15. However, the supporting endogenous energy sources appear to be exhausted during longer substrate-free incubations as indicated by the determined low remaining cellular ATP content that accounted for only around 10% of the initial ATP content after 6&#x000a0;h of incubation. Neither this additional starvation period nor any of the many other conditions applied for studying ATP restoration during 6&#x000a0;h incubations following a 60&#x000a0;min ATP depletion by BAM15 in glucose-deprived astrocytes caused any obvious cell toxicity. This is consistent with the reported transient resistance of cultured starved astrocytes against a substantial loss in the cellular ATP content [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p><p id="Par44">The presence of glucose during the restoration period enabled BAM15-treated astrocytes to slowly restore their ATP content. Only little ATP was gained by the cells within 60&#x000a0;min after glucose-application, consistent with literature data describing a rather limited ATP restoration for short time incubations after application of glucose and other energy substrates to cultured astrocytes [<xref ref-type="bibr" rid="CR30">30</xref>]. Nevertheless, after 6&#x000a0;h of incubation in glucose-containing buffer the cells had restored 80% of their initial cellular ATP content. For this ATP restoration new AMP had to be formed to compensate for the loss in cellular adenosine phosphates observed during the BAM15-treatment. Two main pathways may contribute in glucose-fed cultured astrocytes to the synthesis of new AMP that is used as cellular precursor to restore ATP, the purine <italic>de novo</italic> synthesis and the purine salvage pathway [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR68">68</xref>&#x02013;<xref ref-type="bibr" rid="CR70">70</xref>]. <italic>De novo</italic> synthesis of purine bases on a ribose phosphate precursor generates inosine monophosphate (IMP) from amino acid precursors and this IMP is subsequently amidated to AMP [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. However, as the presence of amino acids does hardly affect ATP restoration during incubations with glucose (data not shown), the <italic>de novo</italic> synthesis of purine nucleoside phosphates appears unlikely to substantially contribute to ATP restoration under the conditions used. This is consistent with the view that <italic>de novo</italic> synthesis of purines is rather low in brain cells, especially after ATP depletion [<xref ref-type="bibr" rid="CR71">71</xref>&#x02013;<xref ref-type="bibr" rid="CR73">73</xref>] and that these cells use mainly the salvage pathway to replenish their purine nucleotide pool [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>].</p><p id="Par45">The salvage pathway uses existing purine bases or purine nucleosides to form IMP and AMP [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Considering that mainly this salvage pathway is providing the AMP as building unit for the observed ATP restoration in the presence of glucose, it remains to elucidate which cellular purines or purine-containing molecules provide the adenine for the net AMP synthesis that is required for ATP restoration. Potential candidates may be residual purine nucleosides and bases that had been generated from AMP during the ATP depletion phase. Alternatively, degradation of cellular RNA may have provided purine nucleotides during the ATP restoration phase in substrate-restricted medium. At least in starved yeast a transient increase of the cellular levels of nucleosides and purine bases was observed that was connected with RNA degradation and starvation-induced autophagy [<xref ref-type="bibr" rid="CR76">76</xref>]. Further studies are required to elucidate in more detail the fate of the adenosine phosphates that disappear from cultured astrocytes during starvation in the presence of BAM15 and to identify the endogenous purine-containing compounds that are used by the cells as precursor for the synthesis of new AMP to enable the cells to restore their ATP.</p><p id="Par46">Compared to glucose incubations, a slower partial ATP restoration was observed for astrocytes that had been incubated during the restoration phase with lactate or pyruvate, while no ATP restoration was observe for incubations with acetate or &#x003b2;-hydroxybutyrate. This supports previous studies, which define lactate, pyruvate, acetate and &#x003b2;-hydroxybutyrate as suitable substrates to maintain the cellular ATP level, but not to restore ATP [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR77">77</xref>&#x02013;<xref ref-type="bibr" rid="CR79">79</xref>]. The reason for this finding may be the need for ribose-5-phosphate as precursor for the phosphoribosyl pyrophosphate (PRPP) that has to be available for the synthesis of purine nucleosides via the salvage pathway [<xref ref-type="bibr" rid="CR60">60</xref>]. As cultured astrocytes are capable to synthesize glucose-6-phosphate from pyruvate and lactate [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>] and have an active pentose-phosphate pathway [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>], these cells may be able to generate some ribose phosphates from pyruvate and lactate. In contrast, although the pure mitochondrial substrates acetate and &#x003b2;-hydroxybutyrate are efficiently consumed by astrocytes to fuel mitochondrial ATP regeneration [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR84">84</xref>], these substrates will be fully oxidized by mitochondrial metabolism and can therefore not provide carbon for net synthesis of ribose phosphates.</p><p id="Par47">The slow ATP restoration in BAM15-preincubated astrocytes after feeding of glucose was strongly accelerated by coapplication of adenosine leading to almost complete ATP restoration already within 60&#x000a0;min. The concentration dependency of the ATP restoration by adenosine revealed that maximal ATP restoration in the presence of glucose was already observed after 60&#x000a0;min incubation with 30 &#x000b5;M adenosine, demonstrating that the use of exogenous adenosine as substrate for the AMP synthesis that is needed for ATP restoration is highly efficient in the presence of glucose as energy substrate. For this condition a net synthesis of around 15 nmol/mg ATP was observed, accounting for the utilization of almost 30% of the extracellularly applied adenosine (7.5 nmol adenosine in 250 &#x000b5;L) as precursor for the AMP needed to restore ATP.</p><p id="Par48">The adenosine-accelerated ATP synthesis was completely prevented by the presence of an inhibitor of adenosine kinase [<xref ref-type="bibr" rid="CR85">85</xref>], demonstrating that adenosine can be efficiently phosphorylated in astrocytes to AMP which is needed as cellular precursor for further ATP restoration. In contrast, inhibitors of adenosine deaminase and/or purine nucleoside phosphorylase did not prevent the accelerated ATP restoration by adenosine, suggesting that synthesis of AMP via IMP and the purine nucleotide salvage pathway [<xref ref-type="bibr" rid="CR60">60</xref>] are unlikely to contribute to the rapid generation of new AMP in ATP-deprived astrocytes after feeding of glucose plus adenosine.</p><p id="Par49">Application of mitochondrial inhibitors revealed that mitochondrial oxidative phosphorylation is not required for the rapid ATP restoration in astrocytes in the presence of glucose plus adenosine, suggesting that the high rate of glycolytic metabolism of the glucose applied is sufficient to promote rapid ATP restoration in the presence of adenosine. This process does not require additional intracellular transport processes between compartments as the adenosine phosphorylating enzyme adenosine kinase is localized in the cytosol [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].</p><p id="Par50">Rapid but only partial ATP restoration was found for BAM15-pretreated astrocytes after application of adenosine as exclusive extracellular substrate. This cellular ATP restoration depended strongly on the adenosine concentration applied and the ATP level initially restored was only maintained in the presence of an additional energy substrate. This suggests for incubations with extracellular adenosine as exclusive substrate that the nucleoside serves both, as precursor for AMP synthesis and as energy substrate to fuel ADP phosphorylation. The presence of exogenous adenosine has previously been reported to prevent a loss in cellular ATP in starved astrocytes, but millimolar concentrations of adenosine were required to fully maintain a high ATP content for 24&#x000a0;h [<xref ref-type="bibr" rid="CR13">13</xref>]. Of the adenosine molecule, only the catabolism of the ribose moiety has to be considered as fuel for energy production. Adenosine is phosphorolytically cleaved by purine nucleoside phosphorylase to adenine and ribose-1-phosphate [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. The ribose phosphate can then be further metabolized in astrocytes by the non-oxidative part of the pentose-phosphate pathway [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>] and by glycolysis to generate pyruvate, which can subsequently be transported into mitochondria and utilized as substrate to fuel mitochondrial oxidative phosphorylation. The contribution of adenosine catabolism in providing energy via ribose phosphates is supported by the potential of inhibitors of the adenosine metabolizing enzymes adenosine deaminase and purine nucleoside phosphorylase to lower ATP restoration from adenosine, if given as exclusive substrate. However, the rate of glycolytic ATP regeneration from adenosine-derived ribose phosphate appears to be too slow in astrocytes to fuel efficient ATP restoration, as inhibition of mitochondrial pyruvate uptake or of oxidative phosphorylation completely prevented ATP restoration from adenosine, while the formation and export of adenosine-derived lactate was found strongly accelerated for such conditions. The poor potential of extracellular adenosine to serve as substrate for glycolysis is also demonstrated by the low levels of basal lactate production and release in adenosine-treated astrocytes, which is at least one order of magnitude lower than the lactate release observed for glucose-treated astrocytes.</p><p id="Par51">In summary, in order to study ATP restoration, cultured astrocytes were first depleted of most of their ATP by a preincubation without energy substrates in the presence of the uncoupler BAM15. Refeeding experiments revealed that this treatment did not compromise the ability of the cells to restore ATP. Astrocytes were found to be highly efficient to fully and rapidly restore their initial high cellular ATP content in the presence of glucose (or another energy substrate) plus adenosine as substrate for adenosine kinase-mediated phosphorylation to AMP.</p><p id="Par52">ATP depletion in brain has been shown to rapidly occur in hypoxic and ischemic conditions [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR86">86</xref>], in stroke [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>] and traumatic head injuries [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. Thus, it is of high importance to better understand the pathways that contribute to ATP restoration in such pathological conditions [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. As astrocytes have important functions in the brain as partners of neurons and as many astrocytic functions require ATP [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR91">91</xref>&#x02013;<xref ref-type="bibr" rid="CR94">94</xref>], a better knowledge on ATP restoration in astrocytes may help to develop strategies to improve astrocytic ATP restoration in pathological conditions. This would help to reestablish important astrocytic functions which in turn would also help neighboring neurons and support the brain during recovery from insults that have lowered the ATP content in brain. However, a direct application of adenosine to foster ATP restoration in brain appears not to be appropriate as adenosine is highly neuroactive [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR95">95</xref>&#x02013;<xref ref-type="bibr" rid="CR101">101</xref>]. Thus, further studies are now required to explore whether adenosine can be replaced by other nucleosides or purine bases for efficient ATP restoration in astrocytes and whether alternative combinations of energy substrates and AMP precursors may support an even better ATP restoration than the combination of glucose plus adenosine.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to acknowledge the financial support of the University of Bremen for the project presented here and thank Paul Spellerberg (University of Bremen) for his help with the statistical analysis of data.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>GK and RD designed the study concept. GK performed most of the experiments, analysed the data obtained and prepared the figures and the tables. JEW obtained some of the experimental data shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and all data shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. ARH contributed a part of the experimental data shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and performed initial experiments on the restoration of the ATP content by starved astrocytes. JEW and PW adapted and optimized the assays used for the quantification of nicotinamide coenzymes. RD wrote the first draft of the manuscript. All authors reviewed and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>Enquieries on original data should be directed to the corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar3" notes-type="COI-statement"><title>Competing Interests</title><p id="Par53">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Verkhratsky</surname><given-names>A</given-names></name><name><surname>Nedergaard</surname><given-names>M</given-names></name></person-group><article-title>Physiology of astroglia</article-title><source>Physiol Rev</source><year>2018</year><volume>98</volume><fpage>239</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1152/physrev.00042.2016</pub-id><pub-id pub-id-type="pmid">29351512</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98:239&#x02013;389. 10.1152/physrev.00042.2016<pub-id pub-id-type="pmid">29351512</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Brazhe</surname><given-names>A</given-names></name><name><surname>Verisokin</surname><given-names>A</given-names></name><name><surname>Verveyko</surname><given-names>D</given-names></name><name><surname>Postnov</surname><given-names>D</given-names></name></person-group><article-title>Astrocytes: new evidence, new models, new roles</article-title><source>Biophys Rev</source><year>2023</year><volume>15</volume><fpage>1303</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1007/s12551-023-01145-7</pub-id><pub-id pub-id-type="pmid">37975000</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Brazhe A, Verisokin A, Verveyko D, Postnov D (2023) Astrocytes: new evidence, new models, new roles. Biophys Rev 15:1303&#x02013;1333. 10.1007/s12551-023-01145-7<pub-id pub-id-type="pmid">37975000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Beard</surname><given-names>E</given-names></name><name><surname>Lengacher</surname><given-names>S</given-names></name><name><surname>Dias</surname><given-names>S</given-names></name><etal/></person-group><article-title>Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives</article-title><source>Front Physiol</source><year>2022</year><volume>12</volume><fpage>825816</fpage><pub-id pub-id-type="doi">10.3389/fphys.2021.825816</pub-id><pub-id pub-id-type="pmid">35087428</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Beard E, Lengacher S, Dias S et al (2022) Astrocytes as key regulators of brain energy metabolism: new therapeutic perspectives. Front Physiol 12:825816. 10.3389/fphys.2021.825816<pub-id pub-id-type="pmid">35087428</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>D</given-names></name><name><surname>Conti</surname><given-names>F</given-names></name></person-group><article-title>Astrocytic Na<sup>+</sup>, K<sup>+</sup> ATPases in physiology and pathophysiology</article-title><source>Cell Calcium</source><year>2024</year><volume>118</volume><fpage>102851</fpage><pub-id pub-id-type="doi">10.1016/j.ceca.2024.102851</pub-id><pub-id pub-id-type="pmid">38308916</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Pietrobon D, Conti F (2024) Astrocytic Na<sup>+</sup>, K<sup>+</sup> ATPases in physiology and pathophysiology. Cell Calcium 118:102851. 10.1016/j.ceca.2024.102851<pub-id pub-id-type="pmid">38308916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>JV</given-names></name><name><surname>Schousboe</surname><given-names>A</given-names></name></person-group><article-title>Milestone review: metabolic dynamics of glutamate and GABA mediated neurotransmission &#x02014; the essential roles of astrocytes</article-title><source>J Neurochem</source><year>2023</year><volume>166</volume><fpage>109</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1111/jnc.15811</pub-id><pub-id pub-id-type="pmid">36919769</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Andersen JV, Schousboe A (2023) Milestone review: metabolic dynamics of glutamate and GABA mediated neurotransmission &#x02014; the essential roles of astrocytes. J Neurochem 166:109&#x02013;137. 10.1111/jnc.15811<pub-id pub-id-type="pmid">36919769</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>S</given-names></name><name><surname>Pahnke</surname><given-names>J</given-names></name></person-group><article-title>Emerging role of ABC transporters in glia cells in health and diseases of the central nervous system</article-title><source>Cells</source><year>2024</year><volume>13</volume><fpage>740</fpage><pub-id pub-id-type="doi">10.3390/cells13090740</pub-id><pub-id pub-id-type="pmid">38727275</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Villa M, Wu J, Hansen S, Pahnke J (2024) Emerging role of ABC transporters in glia cells in health and diseases of the central nervous system. Cells 13:740. 10.3390/cells13090740<pub-id pub-id-type="pmid">38727275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Multidrug resistance protein 1-mediated export of glutathione and glutathione disulfide from brain astrocytes</article-title><source>Methods Enzymol</source><year>2005</year><volume>400</volume><fpage>395</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(05)00023-6</pub-id><pub-id pub-id-type="pmid">16399362</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Hirrlinger J, Dringen R (2005) Multidrug resistance protein 1-mediated export of glutathione and glutathione disulfide from brain astrocytes. Methods Enzymol 400:395&#x02013;409. 10.1016/S0076-6879(05)00023-6<pub-id pub-id-type="pmid">16399362</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="book"><person-group person-group-type="author"><name><surname>Duran</surname><given-names>J</given-names></name><name><surname>Gruart</surname><given-names>A</given-names></name><name><surname>L&#x000f3;pez-Ramos</surname><given-names>JC</given-names></name><etal/><etal/></person-group><person-group person-group-type="editor"><name><surname>DiNuzzo</surname><given-names>M</given-names></name><name><surname>Schousboe</surname><given-names>A</given-names></name><etal/><etal/></person-group><article-title>Glycogen in astrocytes and neurons: physiological and pathological aspects</article-title><source>Brain glycogen metabolism</source><year>2019</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><fpage>311</fpage><lpage>329</lpage></element-citation><mixed-citation id="mc-CR8" publication-type="book">Duran J, Gruart A, L&#x000f3;pez-Ramos JC et al (2019) Glycogen in astrocytes and neurons: physiological and pathological aspects. In: DiNuzzo M, Schousboe A (eds) Brain glycogen metabolism. Springer International Publishing, Cham, pp 311&#x02013;329</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Rich</surname><given-names>LR</given-names></name><name><surname>Harris</surname><given-names>W</given-names></name><name><surname>Brown</surname><given-names>AM</given-names></name></person-group><article-title>The role of brain glycogen in supporting physiological function</article-title><source>Front NeuroSci</source><year>2019</year><volume>13</volume><fpage>1176</fpage><pub-id pub-id-type="doi">10.3389/fnins.2019.01176</pub-id><pub-id pub-id-type="pmid">31749677</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Rich LR, Harris W, Brown AM (2019) The role of brain glycogen in supporting physiological function. Front NeuroSci 13:1176. 10.3389/fnins.2019.01176<pub-id pub-id-type="pmid">31749677</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JA</given-names></name><name><surname>Hall</surname><given-names>B</given-names></name><name><surname>Allsop</surname><given-names>J</given-names></name><etal/></person-group><article-title>Lipid metabolism in astrocytic structure and function</article-title><source>Semin Cell Dev Biol</source><year>2021</year><volume>112</volume><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2020.07.017</pub-id><pub-id pub-id-type="pmid">32773177</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Lee JA, Hall B, Allsop J et al (2021) Lipid metabolism in astrocytic structure and function. Semin Cell Dev Biol 112:123&#x02013;136. 10.1016/j.semcdb.2020.07.017<pub-id pub-id-type="pmid">32773177</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Denker</surname><given-names>N</given-names></name><name><surname>Harders</surname><given-names>AR</given-names></name><name><surname>Arend</surname><given-names>C</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Consumption and metabolism of extracellular pyruvate by cultured rat brain astrocytes</article-title><source>Neurochem Res</source><year>2023</year><volume>48</volume><fpage>1438</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.1007/s11064-022-03831-6</pub-id><pub-id pub-id-type="pmid">36495387</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Denker N, Harders AR, Arend C, Dringen R (2023) Consumption and metabolism of extracellular pyruvate by cultured rat brain astrocytes. Neurochem Res 48:1438&#x02013;1454. 10.1007/s11064-022-03831-6<pub-id pub-id-type="pmid">36495387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Harders</surname><given-names>AR</given-names></name><name><surname>Arend</surname><given-names>C</given-names></name><name><surname>Denieffe</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Endogenous energy stores maintain a high ATP concentration for hours in glucose-depleted cultured primary rat astrocytes</article-title><source>Neurochem Res</source><year>2023</year><volume>48</volume><fpage>2241</fpage><lpage>2252</lpage><pub-id pub-id-type="doi">10.1007/s11064-023-03903-1</pub-id><pub-id pub-id-type="pmid">36914795</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Harders AR, Arend C, Denieffe SC et al (2023) Endogenous energy stores maintain a high ATP concentration for hours in glucose-depleted cultured primary rat astrocytes. Neurochem Res 48:2241&#x02013;2252. 10.1007/s11064-023-03903-1<pub-id pub-id-type="pmid">36914795</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Harders</surname><given-names>AR</given-names></name><name><surname>Spellerberg</surname><given-names>P</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Exogenous substrates prevent the decline in the cellular ATP content of primary rat astrocytes during glucose deprivation</article-title><source>Neurochem Res</source><year>2024</year><volume>49</volume><fpage>1188</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1007/s11064-024-04104-0</pub-id><pub-id pub-id-type="pmid">38341839</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Harders AR, Spellerberg P, Dringen R (2024) Exogenous substrates prevent the decline in the cellular ATP content of primary rat astrocytes during glucose deprivation. Neurochem Res 49:1188&#x02013;1199. 10.1007/s11064-024-04104-0<pub-id pub-id-type="pmid">38341839</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Karger</surname><given-names>G</given-names></name><name><surname>Berger</surname><given-names>J</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Modulation of cellular levels of adenosine phosphates and creatine phosphate in cultured primary astrocytes</article-title><source>Neurochem Res</source><year>2024</year><volume>49</volume><fpage>402</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1007/s11064-023-04039-y</pub-id><pub-id pub-id-type="pmid">37855866</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Karger G, Berger J, Dringen R (2024) Modulation of cellular levels of adenosine phosphates and creatine phosphate in cultured primary astrocytes. Neurochem Res 49:402&#x02013;414. 10.1007/s11064-023-04039-y<pub-id pub-id-type="pmid">37855866</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Hertz</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Dienel</surname><given-names>GA</given-names></name></person-group><article-title>Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis</article-title><source>J Cereb Blood Flow Metab</source><year>2007</year><volume>27</volume><fpage>219</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600343</pub-id><pub-id pub-id-type="pmid">16835632</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Hertz L, Peng L, Dienel GA (2007) Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 27:219&#x02013;249. 10.1038/sj.jcbfm.9600343<pub-id pub-id-type="pmid">16835632</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Supplie</surname><given-names>LM</given-names></name><name><surname>D&#x000fc;king</surname><given-names>T</given-names></name><name><surname>Campbell</surname><given-names>G</given-names></name><etal/></person-group><article-title>Respiration-deficient astrocytes survive as glycolytic cells in vivo</article-title><source>J Neurosci</source><year>2017</year><volume>37</volume><fpage>4231</fpage><lpage>4242</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0756-16.2017</pub-id><pub-id pub-id-type="pmid">28314814</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Supplie LM, D&#x000fc;king T, Campbell G et al (2017) Respiration-deficient astrocytes survive as glycolytic cells in vivo. J Neurosci 37:4231&#x02013;4242. 10.1523/JNEUROSCI.0756-16.2017<pub-id pub-id-type="pmid">28314814</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Arend</surname><given-names>C</given-names></name><name><surname>Ehrke</surname><given-names>E</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Consequences of a metabolic glucose-depletion on the survival and the metabolism of cultured rat astrocytes</article-title><source>Neurochem Res</source><year>2019</year><volume>44</volume><fpage>2288</fpage><lpage>2300</lpage><pub-id pub-id-type="doi">10.1007/s11064-019-02752-1</pub-id><pub-id pub-id-type="pmid">30788754</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Arend C, Ehrke E, Dringen R (2019) Consequences of a metabolic glucose-depletion on the survival and the metabolism of cultured rat astrocytes. Neurochem Res 44:2288&#x02013;2300. 10.1007/s11064-019-02752-1<pub-id pub-id-type="pmid">30788754</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Harders AR, Watermann P, Karger G et al (2024) Consequences of a 2-deoxyglucose exposure on the ATP content and the cytosolic glucose metabolism of cultured primary rat astrocytes. Neurochemical Research 49:3244-3262. 10.1007/s11064-024-04192-y</mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Longuemare</surname><given-names>MC</given-names></name><name><surname>Hill</surname><given-names>MP</given-names></name><name><surname>Swanson</surname><given-names>RA</given-names></name></person-group><article-title>Glycolysis can prevent non-synaptic excitatory amino acid release during hypoxia</article-title><source>NeuroReport</source><year>1994</year><volume>5</volume><fpage>1789</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1097/00001756-199409080-00026</pub-id><pub-id pub-id-type="pmid">7827333</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Longuemare MC, Hill MP, Swanson RA (1994) Glycolysis can prevent non-synaptic excitatory amino acid release during hypoxia. NeuroReport 5:1789&#x02013;1792. 10.1097/00001756-199409080-00026<pub-id pub-id-type="pmid">7827333</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Rutledge</surname><given-names>EM</given-names></name><name><surname>Mongin</surname><given-names>AA</given-names></name><name><surname>Kimelberg</surname><given-names>HK</given-names></name></person-group><article-title>Intracellular ATP depletion inhibits swelling-induced D-w3Hxaspartate release from primary astrocyte cultures</article-title><source>Brain Res</source><year>1999</year><volume>842</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/s0006-8993(99)01805-3</pub-id><pub-id pub-id-type="pmid">10526093</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Rutledge EM, Mongin AA, Kimelberg HK (1999) Intracellular ATP depletion inhibits swelling-induced D-w3Hxaspartate release from primary astrocyte cultures. Brain Res 842:39&#x02013;45. 10.1016/s0006-8993(99)01805-3<pub-id pub-id-type="pmid">10526093</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Nodin</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Blomgren</surname><given-names>K</given-names></name><etal/></person-group><article-title>Decreased oxidative stress during glycolytic inhibition enables maintenance of ATP production and astrocytic survival</article-title><source>Neurochem Int</source><year>2012</year><volume>61</volume><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2012.05.017</pub-id><pub-id pub-id-type="pmid">22634249</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Nodin C, Zhu C, Blomgren K et al (2012) Decreased oxidative stress during glycolytic inhibition enables maintenance of ATP production and astrocytic survival. Neurochem Int 61:291&#x02013;301. 10.1016/j.neuint.2012.05.017<pub-id pub-id-type="pmid">22634249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>CS</given-names></name><name><surname>Bach</surname><given-names>MD</given-names></name><name><surname>Ashkavand</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Metabolic constraints of swelling-activated glutamate release in astrocytes and their implication for ischemic tissue damage</article-title><source>J Neurochem</source><year>2019</year><volume>151</volume><fpage>255</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1111/jnc.14711</pub-id><pub-id pub-id-type="pmid">31032919</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Wilson CS, Bach MD, Ashkavand Z et al (2019) Metabolic constraints of swelling-activated glutamate release in astrocytes and their implication for ischemic tissue damage. J Neurochem 151:255&#x02013;272. 10.1111/jnc.14711<pub-id pub-id-type="pmid">31032919</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>O</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Metabolic and biosynthetic alterations in cultured astrocytes exposed to hypoxia/reoxygenation</article-title><source>J Neurochem</source><year>2008</year><volume>62</volume><fpage>1489</fpage><lpage>1495</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.1994.62041489.x</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Hori O, Matsumoto M, Maeda Y et al (2008) Metabolic and biosynthetic alterations in cultured astrocytes exposed to hypoxia/reoxygenation. J Neurochem 62:1489&#x02013;1495. 10.1046/j.1471-4159.1994.62041489.x</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Zoref-Shani</surname><given-names>E</given-names></name><name><surname>Bromberg</surname><given-names>Y</given-names></name><name><surname>Lilling</surname><given-names>G</given-names></name><etal/></person-group><article-title>Developmental changes in purine nucleotide metabolism in cultured rat astroglia</article-title><source>Int J Dev Neurosci</source><year>1995</year><volume>13</volume><fpage>887</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1016/0736-5748(95)00054-2</pub-id><pub-id pub-id-type="pmid">8770661</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Zoref-Shani E, Bromberg Y, Lilling G et al (1995) Developmental changes in purine nucleotide metabolism in cultured rat astroglia. Int J Dev Neurosci 13:887&#x02013;896. 10.1016/0736-5748(95)00054-2<pub-id pub-id-type="pmid">8770661</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhardt</surname><given-names>R</given-names></name><name><surname>Manaenko</surname><given-names>A</given-names></name><name><surname>Pissarek</surname><given-names>M</given-names></name><etal/></person-group><article-title>Alterations of purine and pyrimidine nucleotide contents in rat corticoencephalic cell cultures following metabolic damage and treatment with openers and blockers of ATP-sensitive potassium channels</article-title><source>Neurochem Int</source><year>2002</year><volume>40</volume><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/S0197-0186(01)00102-4</pub-id><pub-id pub-id-type="pmid">11821150</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Reinhardt R, Manaenko A, Pissarek M et al (2002) Alterations of purine and pyrimidine nucleotide contents in rat corticoencephalic cell cultures following metabolic damage and treatment with openers and blockers of ATP-sensitive potassium channels. Neurochem Int 40:427&#x02013;433. 10.1016/S0197-0186(01)00102-4<pub-id pub-id-type="pmid">11821150</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>KS</given-names></name><name><surname>Suh</surname><given-names>SW</given-names></name><name><surname>Alano</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity</article-title><source>Glia</source><year>2010</year><volume>58</volume><fpage>446</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1002/glia.20936</pub-id><pub-id pub-id-type="pmid">19795500</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Tang KS, Suh SW, Alano CC et al (2010) Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity. Glia 58:446&#x02013;457. 10.1002/glia.20936<pub-id pub-id-type="pmid">19795500</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>DP</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Geiger</surname><given-names>JD</given-names></name><name><surname>Rosenberger</surname><given-names>TA</given-names></name></person-group><article-title>A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures</article-title><source>J Chromatogr B Anal Technol Biomedical Life Sci</source><year>2012</year><volume>889&#x02013;890</volume><fpage>110</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2012.02.005</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Bhatt DP, Chen X, Geiger JD, Rosenberger TA (2012) A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures. J Chromatogr B Anal Technol Biomedical Life Sci 889&#x02013;890:110&#x02013;115. 10.1016/j.jchromb.2012.02.005</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>DE</given-names></name><name><surname>Walton</surname><given-names>GM</given-names></name></person-group><article-title>Adenosine triphosphate conservation in metabolic regulation</article-title><source>J Biol Chem</source><year>1967</year><volume>242</volume><fpage>3239</fpage><lpage>3241</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)95956-9</pub-id><pub-id pub-id-type="pmid">6027798</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Atkinson DE, Walton GM (1967) Adenosine triphosphate conservation in metabolic regulation. J Biol Chem 242:3239&#x02013;3241. 10.1016/S0021-9258(18)95956-9<pub-id pub-id-type="pmid">6027798</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>De La Fuente</surname><given-names>IM</given-names></name><name><surname>Cort&#x000e9;s</surname><given-names>JM</given-names></name><name><surname>Valero</surname><given-names>E</given-names></name><etal/></person-group><article-title>On the dynamics of the adenylate energy system: homeorhesis vs homeostasis</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e108676</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0108676</pub-id><pub-id pub-id-type="pmid">25303477</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">De La Fuente IM, Cort&#x000e9;s JM, Valero E et al (2014) On the dynamics of the adenylate energy system: homeorhesis vs homeostasis. PLoS ONE 9:e108676. 10.1371/journal.pone.0108676<pub-id pub-id-type="pmid">25303477</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Mertens-Strijthagen</surname><given-names>J</given-names></name><name><surname>Lacremans-Pirsoul</surname><given-names>J</given-names></name><name><surname>Baudoux</surname><given-names>G</given-names></name></person-group><article-title>Recovery potential in glucose deprived astrocytes</article-title><source>Neurosci Res</source><year>1996</year><volume>26</volume><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/S0168-0102(96)01081-4</pub-id><pub-id pub-id-type="pmid">8953575</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Mertens-Strijthagen J, Lacremans-Pirsoul J, Baudoux G (1996) Recovery potential in glucose deprived astrocytes. Neurosci Res 26:133&#x02013;139. 10.1016/S0168-0102(96)01081-4<pub-id pub-id-type="pmid">8953575</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>B</given-names></name><name><surname>S&#x000e1;nchez-Abarca</surname><given-names>LI</given-names></name><name><surname>Bola&#x000f1;os</surname><given-names>JP</given-names></name><name><surname>Medina</surname><given-names>JM</given-names></name></person-group><article-title>Inhibition of astrocyte gap junctional communication by ATP depletion is reversed by calcium sequestration</article-title><source>FEBS Lett</source><year>1996</year><volume>392</volume><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(96)00794-6</pub-id><pub-id pub-id-type="pmid">8774849</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Vera B, S&#x000e1;nchez-Abarca LI, Bola&#x000f1;os JP, Medina JM (1996) Inhibition of astrocyte gap junctional communication by ATP depletion is reversed by calcium sequestration. FEBS Lett 392:225&#x02013;228. 10.1016/0014-5793(96)00794-6<pub-id pub-id-type="pmid">8774849</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>ACH</given-names></name><name><surname>Lau</surname><given-names>AMF</given-names></name><name><surname>Fu</surname><given-names>AWY</given-names></name><etal/></person-group><article-title>Changes of ATP and ADP in cultured astrocytes under and after in vitro ischemia</article-title><source>Neurochem Res</source><year>2002</year><volume>27</volume><fpage>1663</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1023/a:1021691112190</pub-id><pub-id pub-id-type="pmid">12515320</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Yu ACH, Lau AMF, Fu AWY et al (2002) Changes of ATP and ADP in cultured astrocytes under and after in vitro ischemia. Neurochem Res 27:1663&#x02013;1668. 10.1023/a:1021691112190<pub-id pub-id-type="pmid">12515320</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="book"><person-group person-group-type="author"><name><surname>Tulpule</surname><given-names>K</given-names></name><name><surname>Hohnholt</surname><given-names>MC</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Waagepetersen</surname><given-names>HS</given-names></name></person-group><article-title>Primary cultures of astrocytes and neurons as model systems to study the metabolism and metabolite export from brain cells</article-title><source>Brain Energy Metabolism</source><year>2014</year><publisher-loc>New York, NY</publisher-loc><publisher-name>Springer New York</publisher-name><fpage>45</fpage><lpage>72</lpage></element-citation><mixed-citation id="mc-CR33" publication-type="book">Tulpule K, Hohnholt MC, Hirrlinger J, Dringen R (2014) Primary cultures of astrocytes and neurons as model systems to study the metabolism and metabolite export from brain cells. In: Hirrlinger J, Waagepetersen HS (eds) Brain Energy Metabolism. Springer New York, New York, NY, pp 45&#x02013;72</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Hamprecht</surname><given-names>B</given-names></name><name><surname>L&#x000f6;ffler</surname><given-names>F</given-names></name></person-group><article-title>Primary glial cultures as a model for studying hormone action</article-title><source>Methods Enzymol</source><year>1985</year><volume>109</volume><fpage>341</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(85)09097-8</pub-id><pub-id pub-id-type="pmid">2985921</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Hamprecht B, L&#x000f6;ffler F (1985) Primary glial cultures as a model for studying hormone action. Methods Enzymol 109:341&#x02013;345. 10.1016/0076-6879(85)09097-8<pub-id pub-id-type="pmid">2985921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Petters</surname><given-names>C</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Comparison of primary and secondary rat astrocyte cultures regarding glucose and glutathione metabolism and the accumulation of iron oxide nanoparticles</article-title><source>Neurochem Res</source><year>2014</year><volume>39</volume><fpage>46</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s11064-013-1189-7</pub-id><pub-id pub-id-type="pmid">24190598</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Petters C, Dringen R (2014) Comparison of primary and secondary rat astrocyte cultures regarding glucose and glutathione metabolism and the accumulation of iron oxide nanoparticles. Neurochem Res 39:46&#x02013;58. 10.1007/s11064-013-1189-7<pub-id pub-id-type="pmid">24190598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Umemura</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Determination of oxidized and reduced nicotinamide adenine dinucleotide in cell monolayers using a single extraction procedure and a spectrophotometric assay</article-title><source>Anal Biochem</source><year>2005</year><volume>338</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2004.10.020</pub-id><pub-id pub-id-type="pmid">15707943</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Umemura K, Kimura H (2005) Determination of oxidized and reduced nicotinamide adenine dinucleotide in cell monolayers using a single extraction procedure and a spectrophotometric assay. Anal Biochem 338:131&#x02013;135. 10.1016/j.ab.2004.10.020<pub-id pub-id-type="pmid">15707943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Zerez</surname><given-names>CR</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Tanaka</surname><given-names>KR</given-names></name></person-group><article-title>Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure</article-title><source>Anal Biochem</source><year>1987</year><volume>164</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(87)90506-9</pub-id><pub-id pub-id-type="pmid">3674385</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Zerez CR, Lee SJ, Tanaka KR (1987) Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal Biochem 164:367&#x02013;373. 10.1016/0003-2697(87)90506-9<pub-id pub-id-type="pmid">3674385</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>O</given-names></name><name><surname>Rosebrough</surname><given-names>N</given-names></name><name><surname>Farr</surname><given-names>A</given-names></name><name><surname>Randall</surname><given-names>R</given-names></name></person-group><article-title>Protein measurement with the Folin phenol reagent</article-title><source>J Biol Chem</source><year>1951</year><volume>193</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)52451-6</pub-id><pub-id pub-id-type="pmid">14907713</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265&#x02013;275. 10.1016/S0021-9258(19)52451-6<pub-id pub-id-type="pmid">14907713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>F</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name></person-group><article-title>The NAD <sup>+</sup> /NADH redox state in astrocytes: independent control of the NAD <sup>+</sup> and NADH content</article-title><source>J Neurosci Res</source><year>2011</year><volume>89</volume><fpage>1956</fpage><lpage>1964</lpage><pub-id pub-id-type="doi">10.1002/jnr.22638</pub-id><pub-id pub-id-type="pmid">21488092</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Wilhelm F, Hirrlinger J (2011) The NAD <sup>+</sup> /NADH redox state in astrocytes: independent control of the NAD <sup>+</sup> and NADH content. J Neurosci Res 89:1956&#x02013;1964. 10.1002/jnr.22638<pub-id pub-id-type="pmid">21488092</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Halestrap</surname><given-names>AP</given-names></name></person-group><article-title>The mechanism of the inhibition of the mitochondrial pyruvate transporter by a-cyanocinnamate derivatives</article-title><source>Biochem J</source><year>1976</year><volume>156</volume><fpage>181</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1042/bj1560181</pub-id><pub-id pub-id-type="pmid">942399</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Halestrap AP (1976) The mechanism of the inhibition of the mitochondrial pyruvate transporter by a-cyanocinnamate derivatives. Biochem J 156:181&#x02013;183. 10.1042/bj1560181<pub-id pub-id-type="pmid">942399</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Phelix</surname><given-names>CF</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name></person-group><article-title>Structural insights into the human mitochondrial pyruvate carrier complexes</article-title><source>J Chem Inf Model</source><year>2021</year><volume>61</volume><fpage>5614</fpage><lpage>5625</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.1c00879</pub-id><pub-id pub-id-type="pmid">34664967</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Xu L, Phelix CF, Chen LY (2021) Structural insights into the human mitochondrial pyruvate carrier complexes. J Chem Inf Model 61:5614&#x02013;5625. 10.1021/acs.jcim.1c00879<pub-id pub-id-type="pmid">34664967</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Denker</surname><given-names>N</given-names></name><name><surname>Dringen</surname><given-names>R</given-names></name></person-group><article-title>Modulation of pyruvate export and extracellular pyruvate concentration in primary asrocyte cultures</article-title><source>Neurochem Res</source><year>2024</year><volume>49</volume><fpage>1331</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1007/s11064-024-04120-0</pub-id><pub-id pub-id-type="pmid">38376749</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Denker N, Dringen R (2024) Modulation of pyruvate export and extracellular pyruvate concentration in primary asrocyte cultures. Neurochem Res 49:1331&#x02013;1346. 10.1007/s11064-024-04120-0<pub-id pub-id-type="pmid">38376749</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Bry&#x00061;&#x00335;</surname><given-names>J</given-names></name><name><surname>Kaniuga</surname><given-names>Z</given-names></name><name><surname>Slater</surname><given-names>EC</given-names></name></person-group><article-title>Studies on the mechanism of inhibition of the mitochondrial electron transport by antimycin. III. Binding of antimycin to sub-mitochondrial particles and to complex III. Biochimica et Biophysica Acta (BBA)</article-title><source>Bioenergetics</source><year>1969</year><volume>189</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/0005-2728(69)90163-7</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Bry&#x00061;&#x00335; J, Kaniuga Z, Slater EC (1969) Studies on the mechanism of inhibition of the mitochondrial electron transport by antimycin. III. Binding of antimycin to sub-mitochondrial particles and to complex III. Biochimica et Biophysica Acta (BBA) -. Bioenergetics 189:327&#x02013;336. 10.1016/0005-2728(69)90163-7</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Kenwood</surname><given-names>BM</given-names></name><name><surname>Weaver</surname><given-names>JL</given-names></name><name><surname>Bajwa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane</article-title><source>Mol Metabolism</source><year>2013</year><volume>3</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2013.11.005</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Kenwood BM, Weaver JL, Bajwa A et al (2013) Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol Metabolism 3:114&#x02013;123. 10.1016/j.molmet.2013.11.005</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group><article-title>BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1252141</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1252141</pub-id><pub-id pub-id-type="pmid">37900126</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Xiong G, Zhang K, Ma Y et al (2023) BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases. Front Endocrinol (Lausanne) 14:1252141. 10.3389/fendo.2023.1252141<pub-id pub-id-type="pmid">37900126</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Elsherbiny</surname><given-names>NM</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Naime</surname><given-names>M</given-names></name><etal/></person-group><article-title>ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy</article-title><source>Life Sci</source><year>2013</year><volume>93</volume><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2013.05.024</pub-id><pub-id pub-id-type="pmid">23770229</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Elsherbiny NM, Ahmad S, Naime M et al (2013) ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. Life Sci 93:78&#x02013;88. 10.1016/j.lfs.2013.05.024<pub-id pub-id-type="pmid">23770229</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Niitsu</surname><given-names>N</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Umeda</surname><given-names>M</given-names></name><name><surname>Honma</surname><given-names>Y</given-names></name></person-group><article-title>Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2&#x02032;-deoxycoformycin and 2&#x02032;-deoxydenosine: aassociation with dATP-dependent activation of caspase-3</article-title><source>Blood</source><year>1998</year><volume>92</volume><fpage>3368</fpage><lpage>3375</lpage><pub-id pub-id-type="doi">10.1182/blood.V92.9.3368</pub-id><pub-id pub-id-type="pmid">9787175</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Niitsu N, Yamaguchi Y, Umeda M, Honma Y (1998) Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2&#x02032;-deoxycoformycin and 2&#x02032;-deoxydenosine: aassociation with dATP-dependent activation of caspase-3. Blood 92:3368&#x02013;3375. 10.1182/blood.V92.9.3368<pub-id pub-id-type="pmid">9787175</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Robak</surname><given-names>T</given-names></name></person-group><article-title>Recent progress in the management of chronic lymphocytic leukemia</article-title><source>Cancer Treat Rev</source><year>2007</year><volume>33</volume><fpage>710</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2007.08.003</pub-id><pub-id pub-id-type="pmid">17904294</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Robak T (2007) Recent progress in the management of chronic lymphocytic leukemia. Cancer Treat Rev 33:710&#x02013;728. 10.1016/j.ctrv.2007.08.003<pub-id pub-id-type="pmid">17904294</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>GB</given-names></name><name><surname>Furneaux</surname><given-names>RH</given-names></name><name><surname>Lewandowicz</surname><given-names>A</given-names></name><etal/></person-group><article-title>Exploring structure&#x02013;&#x02009;activity relationships of transition state analogues of human purine nucleoside phosphorylase</article-title><source>J Med Chem</source><year>2003</year><volume>46</volume><fpage>3412</fpage><lpage>3423</lpage><pub-id pub-id-type="doi">10.1021/jm030145r</pub-id><pub-id pub-id-type="pmid">12852771</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Evans GB, Furneaux RH, Lewandowicz A et al (2003) Exploring structure&#x02013;&#x02009;activity relationships of transition state analogues of human purine nucleoside phosphorylase. J Med Chem 46:3412&#x02013;3423. 10.1021/jm030145r<pub-id pub-id-type="pmid">12852771</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Mizukoshi T, Yamada S, Sakakibara S (2023) Spatiotemporal regulation of de novo and salvage purine synthesis during brain development. eNeuro 10. 10.1523/ENEURO.0159-23.2023. ENEURO.0159-23.2023</mixed-citation></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Lenaz</surname><given-names>G</given-names></name></person-group><article-title>Role of mitochondria in oxidative stress and ageing. Biochimica et Biophysica Acta (BBA)</article-title><source>- Bioenergetics</source><year>1998</year><volume>1366</volume><fpage>53</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S0005-2728(98)00120-0</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Lenaz G (1998) Role of mitochondria in oxidative stress and ageing. Biochimica et Biophysica Acta (BBA). - Bioenergetics 1366:53&#x02013;67. 10.1016/S0005-2728(98)00120-0</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>CS</given-names></name><name><surname>Teixeira</surname><given-names>MH</given-names></name><name><surname>Russell</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Mechanism of rotenone binding to respiratory complex I depends on ligand flexibility</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>6738</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-33333-6</pub-id><pub-id pub-id-type="pmid">37185607</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Pereira CS, Teixeira MH, Russell DA et al (2023) Mechanism of rotenone binding to respiratory complex I depends on ligand flexibility. Sci Rep 13:6738. 10.1038/s41598-023-33333-6<pub-id pub-id-type="pmid">37185607</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>C-PB</given-names></name><name><surname>Tsao</surname><given-names>C-C</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group><article-title>Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>12647</fpage><lpage>12654</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.084194</pub-id><pub-id pub-id-type="pmid">20110356</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Hao W, Chang C-PB, Tsao C-C, Xu J (2010) Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J Biol Chem 285:12647&#x02013;12654. 10.1074/jbc.M109.084194<pub-id pub-id-type="pmid">20110356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>EA</given-names></name><name><surname>Dalla Costa</surname><given-names>AP</given-names></name><name><surname>Ruas</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Proliferating astrocytes in primary culture do not depend upon mitochondrial respiratory complex I activity or oxidative phosphorylation</article-title><source>Cells</source><year>2023</year><volume>12</volume><fpage>683</fpage><pub-id pub-id-type="doi">10.3390/cells12050683</pub-id><pub-id pub-id-type="pmid">36899819</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Silva EA, Dalla Costa AP, Ruas JS et al (2023) Proliferating astrocytes in primary culture do not depend upon mitochondrial respiratory complex I activity or oxidative phosphorylation. Cells 12:683. 10.3390/cells12050683<pub-id pub-id-type="pmid">36899819</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Manos</surname><given-names>P</given-names></name><name><surname>Bryan</surname><given-names>GK</given-names></name><name><surname>Edmond</surname><given-names>J</given-names></name></person-group><article-title>Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes</article-title><source>J Neurochem</source><year>1991</year><volume>56</volume><fpage>2101</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1991.tb03472.x</pub-id><pub-id pub-id-type="pmid">2027017</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Manos P, Bryan GK, Edmond J (1991) Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes. J Neurochem 56:2101&#x02013;2107. 10.1111/j.1471-4159.1991.tb03472.x<pub-id pub-id-type="pmid">2027017</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>K</given-names></name></person-group><article-title>Regulation of adenine nucleotide metabolism by adenylate kinase isozymes: physiological roles and diseases</article-title><source>Int J Mol Sci</source><year>2023</year><volume>24</volume><fpage>5561</fpage><pub-id pub-id-type="doi">10.3390/ijms24065561</pub-id><pub-id pub-id-type="pmid">36982634</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Fujisawa K (2023) Regulation of adenine nucleotide metabolism by adenylate kinase isozymes: physiological roles and diseases. Int J Mol Sci 24:5561. 10.3390/ijms24065561<pub-id pub-id-type="pmid">36982634</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Zur Nedden</surname><given-names>S</given-names></name><name><surname>Hawley</surname><given-names>S</given-names></name><name><surname>Pentland</surname><given-names>N</given-names></name><etal/></person-group><article-title>Intracellular ATP influences synaptic plasticity in area CA1 of rat hippocampus via metabolism to adenosine and activity-dependent activation of adenosine A1 receptors</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>6221</fpage><lpage>6234</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4039-10.2011</pub-id><pub-id pub-id-type="pmid">21508245</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Zur Nedden S, Hawley S, Pentland N et al (2011) Intracellular ATP influences synaptic plasticity in area CA1 of rat hippocampus via metabolism to adenosine and activity-dependent activation of adenosine A1 receptors. J Neurosci 31:6221&#x02013;6234. 10.1523/JNEUROSCI.4039-10.2011<pub-id pub-id-type="pmid">21508245</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Frenguelli</surname><given-names>BG</given-names></name></person-group><article-title>The purine salvage pathway and the restoration of cerebral ATP: implications for brain slice physiology and brain injury</article-title><source>Neurochem Res</source><year>2019</year><volume>44</volume><fpage>661</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1007/s11064-017-2386-6</pub-id><pub-id pub-id-type="pmid">28836168</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Frenguelli BG (2019) The purine salvage pathway and the restoration of cerebral ATP: implications for brain slice physiology and brain injury. Neurochem Res 44:661&#x02013;675. 10.1007/s11064-017-2386-6<pub-id pub-id-type="pmid">28836168</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Gil</surname><given-names>M</given-names></name><name><surname>Camici</surname><given-names>M</given-names></name><name><surname>Allegrini</surname><given-names>S</given-names></name><etal/></person-group><article-title>Metabolic aspects of adenosine functions in the brain</article-title><source>Front Pharmacol</source><year>2021</year><volume>12</volume><fpage>672182</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.672182</pub-id><pub-id pub-id-type="pmid">34054547</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Garcia-Gil M, Camici M, Allegrini S et al (2021) Metabolic aspects of adenosine functions in the brain. Front Pharmacol 12:672182. 10.3389/fphar.2021.672182<pub-id pub-id-type="pmid">34054547</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Gessner</surname><given-names>P</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><name><surname>Frenguelli</surname><given-names>BG</given-names></name></person-group><article-title>The mammalian purine salvage pathway as an exploitable route for cerebral bioenergetic support after brain injury</article-title><source>Neuropharmacology</source><year>2023</year><volume>224</volume><fpage>109370</fpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2022.109370</pub-id><pub-id pub-id-type="pmid">36493858</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Gessner P, Lum J, Frenguelli BG (2023) The mammalian purine salvage pathway as an exploitable route for cerebral bioenergetic support after brain injury. Neuropharmacology 224:109370. 10.1016/j.neuropharm.2022.109370<pub-id pub-id-type="pmid">36493858</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>1,5-Diaminonaphthalene hydrochloride assisted laser desorption/ionization mass spectrometry imaging of small molecules in tissues following focal cerebral ischemia</article-title><source>Anal Chem</source><year>2014</year><volume>86</volume><fpage>10114</fpage><lpage>10121</lpage><pub-id pub-id-type="doi">10.1021/ac5034566</pub-id><pub-id pub-id-type="pmid">25247713</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Liu H, Chen R, Wang J et al (2014) 1,5-Diaminonaphthalene hydrochloride assisted laser desorption/ionization mass spectrometry imaging of small molecules in tissues following focal cerebral ischemia. Anal Chem 86:10114&#x02013;10121. 10.1021/ac5034566<pub-id pub-id-type="pmid">25247713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname><given-names>IA</given-names></name><name><surname>Esteve</surname><given-names>C</given-names></name><name><surname>Wermer</surname><given-names>MJH</given-names></name><etal/></person-group><article-title>Funnel-freezing versus heat-stabilization for the visualization of metabolites by mass spectrometry imaging in a mouse stroke model</article-title><source>Proteomics</source><year>2016</year><volume>16</volume><fpage>1652</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1002/pmic.201500402</pub-id><pub-id pub-id-type="pmid">26959721</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Mulder IA, Esteve C, Wermer MJH et al (2016) Funnel-freezing versus heat-stabilization for the visualization of metabolites by mass spectrometry imaging in a mouse stroke model. Proteomics 16:1652&#x02013;1659. 10.1002/pmic.201500402<pub-id pub-id-type="pmid">26959721</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>AMPK: positive and negative regulation, and its role in whole-body energy homeostasis</article-title><source>Curr Opin Cell Biol</source><year>2015</year><volume>33</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2014.09.004</pub-id><pub-id pub-id-type="pmid">25259783</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Hardie DG (2015) AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol 33:1&#x02013;7. 10.1016/j.ceb.2014.09.004<pub-id pub-id-type="pmid">25259783</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname><given-names>P</given-names></name><name><surname>Khan</surname><given-names>H</given-names></name><name><surname>Singh</surname><given-names>TG</given-names></name><name><surname>Grewal</surname><given-names>AK</given-names></name></person-group><article-title>Mechanistic insights on impact of Adenosine monophosphate-activated protein kinase (AMPK) mediated signalling pathways on cerebral ischemic injury</article-title><source>Neurosci Res</source><year>2023</year><volume>190</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.neures.2022.11.006</pub-id><pub-id pub-id-type="pmid">36403790</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Kalra P, Khan H, Singh TG, Grewal AK (2023) Mechanistic insights on impact of Adenosine monophosphate-activated protein kinase (AMPK) mediated signalling pathways on cerebral ischemic injury. Neurosci Res 190:17&#x02013;28. 10.1016/j.neures.2022.11.006<pub-id pub-id-type="pmid">36403790</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Muraleedharan</surname><given-names>R</given-names></name><name><surname>Dasgupta</surname><given-names>B</given-names></name></person-group><article-title>AMPK in the brain: its roles in glucose and neural metabolism</article-title><source>FEBS J</source><year>2022</year><volume>289</volume><fpage>2247</fpage><lpage>2262</lpage><pub-id pub-id-type="doi">10.1111/febs.16151</pub-id><pub-id pub-id-type="pmid">34355526</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Muraleedharan R, Dasgupta B (2022) AMPK in the brain: its roles in glucose and neural metabolism. FEBS J 289:2247&#x02013;2262. 10.1111/febs.16151<pub-id pub-id-type="pmid">34355526</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Panayiotou</surname><given-names>C</given-names></name><name><surname>Solaroli</surname><given-names>N</given-names></name><name><surname>Karlsson</surname><given-names>A</given-names></name></person-group><article-title>The many isoforms of human adenylate kinases</article-title><source>Int J Biochem Cell Biol</source><year>2014</year><volume>49</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2014.01.014</pub-id><pub-id pub-id-type="pmid">24495878</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Panayiotou C, Solaroli N, Karlsson A (2014) The many isoforms of human adenylate kinases. Int J Biochem Cell Biol 49:75&#x02013;83. 10.1016/j.biocel.2014.01.014<pub-id pub-id-type="pmid">24495878</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Yager</surname><given-names>JY</given-names></name><name><surname>Kala</surname><given-names>G</given-names></name><name><surname>Hertz</surname><given-names>L</given-names></name><name><surname>Juurlink</surname><given-names>BHJ</given-names></name></person-group><article-title>Correlation between content of high-energy phosphates and hypoxic-ischemic damage in immature and mature astrocytes</article-title><source>Dev Brain Res</source><year>1994</year><volume>82</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/0165-3806(94)90148-1</pub-id><pub-id pub-id-type="pmid">7842520</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Yager JY, Kala G, Hertz L, Juurlink BHJ (1994) Correlation between content of high-energy phosphates and hypoxic-ischemic damage in immature and mature astrocytes. Dev Brain Res 82:62&#x02013;68. 10.1016/0165-3806(94)90148-1<pub-id pub-id-type="pmid">7842520</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Dewulf</surname><given-names>JP</given-names></name><name><surname>Marie</surname><given-names>S</given-names></name><name><surname>Nassogne</surname><given-names>M-C</given-names></name></person-group><article-title>Disorders of purine biosynthesis metabolism</article-title><source>Mol Genet Metab</source><year>2022</year><volume>136</volume><fpage>190</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2021.12.016</pub-id><pub-id pub-id-type="pmid">34998670</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Dewulf JP, Marie S, Nassogne M-C (2022) Disorders of purine biosynthesis metabolism. Mol Genet Metab 136:190&#x02013;198. 10.1016/j.ymgme.2021.12.016<pub-id pub-id-type="pmid">34998670</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Camici</surname><given-names>M</given-names></name><name><surname>Garcia-Gil</surname><given-names>M</given-names></name><name><surname>Allegrini</surname><given-names>S</given-names></name><etal/></person-group><article-title>Inborn errors of purine salvage and catabolism</article-title><source>Metabolites</source><year>2023</year><volume>13</volume><fpage>787</fpage><pub-id pub-id-type="doi">10.3390/metabo13070787</pub-id><pub-id pub-id-type="pmid">37512494</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Camici M, Garcia-Gil M, Allegrini S et al (2023) Inborn errors of purine salvage and catabolism. Metabolites 13:787. 10.3390/metabo13070787<pub-id pub-id-type="pmid">37512494</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Brain energy metabolism: astrocytes in neurodegenerative diseases</article-title><source>CNS Neurosci Ther</source><year>2022</year><volume>00</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/cns.13982</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Chen Z, Yuan Z, Yang S et al (2022) Brain energy metabolism: astrocytes in neurodegenerative diseases. CNS Neurosci Ther 00:1&#x02013;13. 10.1111/cns.13982</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>E</given-names></name><name><surname>Marko</surname><given-names>P</given-names></name><name><surname>Zimmer</surname><given-names>H-G</given-names></name><etal/></person-group><article-title>Different response of adenine nucleotide synthesis de novo in kidney and brain during aerobic recovery from anoxia and ischemia</article-title><source>Experientia</source><year>1971</year><volume>27</volume><fpage>876</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1007/BF02135716</pub-id><pub-id pub-id-type="pmid">5139222</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Gerlach E, Marko P, Zimmer H-G et al (1971) Different response of adenine nucleotide synthesis de novo in kidney and brain during aerobic recovery from anoxia and ischemia. Experientia 27:876&#x02013;878. 10.1007/BF02135716<pub-id pub-id-type="pmid">5139222</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Barsotti</surname><given-names>C</given-names></name><name><surname>Tozzi</surname><given-names>MG</given-names></name><name><surname>Ipata</surname><given-names>PL</given-names></name></person-group><article-title>Purine and pyrimidine salvage in whole rat brain</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>9865</fpage><lpage>9869</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111418200</pub-id><pub-id pub-id-type="pmid">11782482</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Barsotti C, Tozzi MG, Ipata PL (2002) Purine and pyrimidine salvage in whole rat brain. J Biol Chem 277:9865&#x02013;9869. 10.1074/jbc.M111418200<pub-id pub-id-type="pmid">11782482</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Ipata</surname><given-names>PL</given-names></name><name><surname>Camici</surname><given-names>M</given-names></name><name><surname>Micheli</surname><given-names>V</given-names></name><name><surname>Tozzi</surname><given-names>G</given-names></name></person-group><article-title>Metabolic network of nucleosides in the brain</article-title><source>Curr Top Med Chem</source><year>2011</year><volume>11</volume><fpage>909</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.2174/156802611795347555</pub-id><pub-id pub-id-type="pmid">21401502</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Ipata PL, Camici M, Micheli V, Tozzi G M (2011) Metabolic network of nucleosides in the brain. Curr Top Med Chem 11:909&#x02013;922. 10.2174/156802611795347555<pub-id pub-id-type="pmid">21401502</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Allsop</surname><given-names>J</given-names></name><name><surname>Watts</surname><given-names>RWE</given-names></name></person-group><article-title>Activities of amidophosphoribosyltransferase (EC 2.4.2.14) and the purine phosphoribosyltransferases (EC 2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development</article-title><source>J Neurol Sci</source><year>1980</year><volume>46</volume><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(80)90080-5</pub-id><pub-id pub-id-type="pmid">6155447</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Allsop J, Watts RWE (1980) Activities of amidophosphoribosyltransferase (EC 2.4.2.14) and the purine phosphoribosyltransferases (EC 2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development. J Neurol Sci 46:221&#x02013;232. 10.1016/0022-510X(80)90080-5<pub-id pub-id-type="pmid">6155447</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Pareek</surname><given-names>V</given-names></name><name><surname>Pedley</surname><given-names>AM</given-names></name><name><surname>Benkovic</surname><given-names>SJ</given-names></name></person-group><article-title>Human de novo purine biosynthesis</article-title><source>Crit Rev Biochem Mol Biol</source><year>2021</year><volume>56</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1080/10409238.2020.1832438</pub-id><pub-id pub-id-type="pmid">33179964</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Pareek V, Pedley AM, Benkovic SJ (2021) Human de novo purine biosynthesis. Crit Rev Biochem Mol Biol 56:1&#x02013;16. 10.1080/10409238.2020.1832438<pub-id pub-id-type="pmid">33179964</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Nasaruddin</surname><given-names>ML</given-names></name><name><surname>Tajul Arifin</surname><given-names>K</given-names></name></person-group><article-title>Application of metabolomics in the study of starvation-induced autophagy in saccharomyces cerevisiae: a scoping review</article-title><source>J Fungi</source><year>2021</year><volume>7</volume><fpage>987</fpage><pub-id pub-id-type="doi">10.3390/jof7110987</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Nasaruddin ML, Tajul Arifin K (2021) Application of metabolomics in the study of starvation-induced autophagy in saccharomyces cerevisiae: a scoping review. J Fungi 7:987. 10.3390/jof7110987</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name></person-group><article-title>Effect of ketone body (D-3-hydroxybutyrate) on neural activity and energy metabolism in hippocampal slices of the adult guinea pig</article-title><source>Neurosci Lett</source><year>1991</year><volume>130</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(91)90225-I</pub-id><pub-id pub-id-type="pmid">1749516</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Arakawa T, Goto T, Okada Y (1991) Effect of ketone body (D-3-hydroxybutyrate) on neural activity and energy metabolism in hippocampal slices of the adult guinea pig. Neurosci Lett 130:53&#x02013;56. 10.1016/0304-3940(91)90225-I<pub-id pub-id-type="pmid">1749516</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Kanatani</surname><given-names>T</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name></person-group><article-title>Effects of glycolytic metabolites on preservation of high energy phosphate level and synaptic transmission in the granule cells of guinea pig hippocampal slices</article-title><source>Experientia</source><year>1995</year><volume>51</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1007/BF01931098</pub-id><pub-id pub-id-type="pmid">7698281</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Kanatani T, Mizuno K, Okada Y (1995) Effects of glycolytic metabolites on preservation of high energy phosphate level and synaptic transmission in the granule cells of guinea pig hippocampal slices. Experientia 51:213&#x02013;216. 10.1007/BF01931098<pub-id pub-id-type="pmid">7698281</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>JM</given-names></name><name><surname>Ludvig</surname><given-names>N</given-names></name><name><surname>Bergold</surname><given-names>PJ</given-names></name></person-group><article-title>Elevated lactate suppresses neuronal firing in vivo and inhibits glucose metabolism in hippocampal slice cultures</article-title><source>Brain Res</source><year>2006</year><volume>1117</volume><fpage>213</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.07.107</pub-id><pub-id pub-id-type="pmid">16996036</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Gilbert E, Tang JM, Ludvig N, Bergold PJ (2006) Elevated lactate suppresses neuronal firing in vivo and inhibits glucose metabolism in hippocampal slice cultures. Brain Res 1117:213&#x02013;223. 10.1016/j.brainres.2006.07.107<pub-id pub-id-type="pmid">16996036</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Dringen</surname><given-names>R</given-names></name><name><surname>Schmoll</surname><given-names>D</given-names></name><name><surname>Cesar</surname><given-names>M</given-names></name><name><surname>Hamprecht</surname><given-names>B</given-names></name></person-group><article-title>Incorporation of radioactivity from [<sup>14</sup>C] lactate into the glycogen of cultured mouse astroglial cells evidence for gluconeogenesis in brain cells</article-title><source>Biol Chem Hoppe-Seyler</source><year>1993</year><volume>374</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1515/bchm3.1993.374.1-6.343</pub-id><pub-id pub-id-type="pmid">8338635</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Dringen R, Schmoll D, Cesar M, Hamprecht B (1993) Incorporation of radioactivity from [<sup>14</sup>C] lactate into the glycogen of cultured mouse astroglial cells evidence for gluconeogenesis in brain cells. Biol Chem Hoppe-Seyler 374:343&#x02013;348. 10.1515/bchm3.1993.374.1-6.343<pub-id pub-id-type="pmid">8338635</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="other">Yip J, Geng X, Shen J, Ding Y (2017) Cerebral gluconeogenesis and diseases. Front Pharmacol 7. 10.3389/fphar.2016.00521</mixed-citation></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="book"><person-group person-group-type="author"><name><surname>Dringen</surname><given-names>R</given-names></name><name><surname>Hoepken</surname><given-names>H</given-names></name><name><surname>Minich</surname><given-names>T</given-names></name><name><surname>Ruedig</surname><given-names>C</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Dienel</surname><given-names>G</given-names></name><name><surname>Gibson</surname><given-names>G</given-names></name></person-group><article-title>Pentose phosphate pathway and NADPH metabolism</article-title><source>Handbook of Neurochemistry and Molecular Neurobiology</source><year>2007</year><publisher-loc>Heidelberg</publisher-loc><publisher-name>Springer</publisher-name><fpage>41</fpage><lpage>62</lpage></element-citation><mixed-citation id="mc-CR82" publication-type="book">Dringen R, Hoepken H, Minich T, Ruedig C (2007) Pentose phosphate pathway and NADPH metabolism. In: Dienel G, Gibson G (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Heidelberg, pp 41&#x02013;62</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group><article-title>Neuroprotective function of high glycolytic activity in astrocytes: common roles in stroke and neurodegenerative diseases</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><fpage>6568</fpage><pub-id pub-id-type="doi">10.3390/ijms22126568</pub-id><pub-id pub-id-type="pmid">34207355</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Takahashi S (2021) Neuroprotective function of high glycolytic activity in astrocytes: common roles in stroke and neurodegenerative diseases. Int J Mol Sci 22:6568. 10.3390/ijms22126568<pub-id pub-id-type="pmid">34207355</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>J</given-names></name><name><surname>Brian</surname><given-names>C</given-names></name><name><surname>Pappa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mitochondrial metabolism in astrocytes regulates brain bioenergetics, neurotransmission and redox balance</article-title><source>Front NeuroSci</source><year>2020</year><volume>14</volume><fpage>536682</fpage><pub-id pub-id-type="doi">10.3389/fnins.2020.536682</pub-id><pub-id pub-id-type="pmid">33224019</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Rose J, Brian C, Pappa A et al (2020) Mitochondrial metabolism in astrocytes regulates brain bioenergetics, neurotransmission and redox balance. Front NeuroSci 14:536682. 10.3389/fnins.2020.536682<pub-id pub-id-type="pmid">33224019</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Aronica</surname><given-names>E</given-names></name><name><surname>Sandau</surname><given-names>US</given-names></name><name><surname>Iyer</surname><given-names>A</given-names></name><name><surname>Boison</surname><given-names>D</given-names></name></person-group><article-title>Glial adenosine kinase&#x02013; A neuropathological marker of the epileptic brain</article-title><source>Neurochem Int</source><year>2013</year><volume>63</volume><fpage>688</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2013.01.028</pub-id><pub-id pub-id-type="pmid">23385089</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Aronica E, Sandau US, Iyer A, Boison D (2013) Glial adenosine kinase&#x02013; A neuropathological marker of the epileptic brain. Neurochem Int 63:688&#x02013;695. 10.1016/j.neuint.2013.01.028<pub-id pub-id-type="pmid">23385089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Hossmann</surname><given-names>K-A</given-names></name></person-group><article-title>Cerebral ischemia: models, methods and outcomes</article-title><source>Neuropharmacology</source><year>2008</year><volume>55</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2007.12.004</pub-id><pub-id pub-id-type="pmid">18222496</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Hossmann K-A (2008) Cerebral ischemia: models, methods and outcomes. Neuropharmacology 55:257&#x02013;270. 10.1016/j.neuropharm.2007.12.004<pub-id pub-id-type="pmid">18222496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>NR</given-names></name><name><surname>Muyderman</surname><given-names>H</given-names></name></person-group><article-title>Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta (BBA)</article-title><source>Mol Basis Disease</source><year>2010</year><volume>1802</volume><fpage>80</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2009.09.003</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Sims NR, Muyderman H (2010) Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta (BBA) -. Mol Basis Disease 1802:80&#x02013;91. 10.1016/j.bbadis.2009.09.003</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000e4;dlich</surname><given-names>IS</given-names></name><name><surname>Winzer</surname><given-names>R</given-names></name><name><surname>Stabernack</surname><given-names>J</given-names></name><etal/></person-group><article-title>The role of the ATP-adenosine axis in ischemic stroke</article-title><source>Semin Immunopathol</source><year>2023</year><volume>45</volume><fpage>347</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1007/s00281-023-00987-3</pub-id><pub-id pub-id-type="pmid">36917241</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Sch&#x000e4;dlich IS, Winzer R, Stabernack J et al (2023) The role of the ATP-adenosine axis in ischemic stroke. Semin Immunopathol 45:347&#x02013;365. 10.1007/s00281-023-00987-3<pub-id pub-id-type="pmid">36917241</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Vagnozzi</surname><given-names>R</given-names></name><name><surname>Signoretti</surname><given-names>S</given-names></name><name><surname>Cristofori</surname><given-names>L</given-names></name><etal/></person-group><article-title>Assessment of metabolic brain damage and recovery following mild traumatic brain injury: a multicentre, proton magnetic resonance spectroscopic study in concussed patients</article-title><source>Brain</source><year>2010</year><volume>133</volume><fpage>3232</fpage><lpage>3242</lpage><pub-id pub-id-type="doi">10.1093/brain/awq200</pub-id><pub-id pub-id-type="pmid">20736189</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Vagnozzi R, Signoretti S, Cristofori L et al (2010) Assessment of metabolic brain damage and recovery following mild traumatic brain injury: a multicentre, proton magnetic resonance spectroscopic study in concussed patients. Brain 133:3232&#x02013;3242. 10.1093/brain/awq200<pub-id pub-id-type="pmid">20736189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>HS</given-names></name><name><surname>Diaz-Arrastia</surname><given-names>RR</given-names></name></person-group><article-title>Diagnosis, prognosis, and clinical management of mild traumatic brain injury</article-title><source>Lancet Neurol</source><year>2015</year><volume>14</volume><fpage>506</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(15)00002-2</pub-id><pub-id pub-id-type="pmid">25801547</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Levin HS, Diaz-Arrastia RR (2015) Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol 14:506&#x02013;517. 10.1016/S1474-4422(15)00002-2<pub-id pub-id-type="pmid">25801547</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="other">Silver IA, Ereci&#x00144;ska M (1997) Energetic demands of the Na<sup>+</sup>/K<sup>+</sup> ATPase in mammalian astrocytes. Glia 21:35&#x02013;45. 10.1002/(SICI)1098-1136(199709)21:1%3C35::AID-GLIA4%3E3.0.CO;2-0</mixed-citation></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>CR</given-names></name><name><surname>Karus</surname><given-names>C</given-names></name></person-group><article-title>Two sides of the same coin: Sodium homeostasis and signaling in astrocytes under physiological and pathophysiological conditions</article-title><source>Glia</source><year>2013</year><volume>61</volume><fpage>1191</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1002/glia.22492</pub-id><pub-id pub-id-type="pmid">23553639</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Rose CR, Karus C (2013) Two sides of the same coin: Sodium homeostasis and signaling in astrocytes under physiological and pathophysiological conditions. Glia 61:1191&#x02013;1205. 10.1002/glia.22492<pub-id pub-id-type="pmid">23553639</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>CF</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name><name><surname>Parpura</surname><given-names>V</given-names></name></person-group><article-title>Astrocyte glutamine synthetase: pivotal in health and disease</article-title><source>Biochem Soc Trans</source><year>2013</year><volume>41</volume><fpage>1518</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1042/BST20130237</pub-id><pub-id pub-id-type="pmid">24256247</pub-id>
</element-citation><mixed-citation id="mc-CR93" publication-type="journal">Rose CF, Verkhratsky A, Parpura V (2013) Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans 41:1518&#x02013;1524. 10.1042/BST20130237<pub-id pub-id-type="pmid">24256247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>JV</given-names></name><name><surname>Schousboe</surname><given-names>A</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group><article-title>Astrocyte energy and neurotransmitter metabolism in Alzheimer&#x02019;s disease: integration of the glutamate/GABA-glutamine cycle</article-title><source>Prog Neurobiol</source><year>2022</year><volume>217</volume><fpage>102331</fpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2022.102331</pub-id><pub-id pub-id-type="pmid">35872221</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Andersen JV, Schousboe A, Verkhratsky A (2022) Astrocyte energy and neurotransmitter metabolism in Alzheimer&#x02019;s disease: integration of the glutamate/GABA-glutamine cycle. Prog Neurobiol 217:102331. 10.1016/j.pneurobio.2022.102331<pub-id pub-id-type="pmid">35872221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>N</given-names></name><name><surname>Frenguelli</surname><given-names>B</given-names></name></person-group><article-title>Release of adenosine and ATP during ischemia and epilepsy</article-title><source>Curr Neuropharmacol</source><year>2009</year><volume>7</volume><fpage>160</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.2174/157015909789152146</pub-id><pub-id pub-id-type="pmid">20190959</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Dale N, Frenguelli B (2009) Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacol 7:160&#x02013;179. 10.2174/157015909789152146<pub-id pub-id-type="pmid">20190959</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>SH</given-names></name><name><surname>Jaafari</surname><given-names>N</given-names></name><name><surname>Cimarosti</surname><given-names>H</given-names></name><etal/></person-group><article-title>Oxygen/glucose deprivation induces a reduction in synaptic AMPA receptors on hippocampal CA3 neurons mediated by mGluR1 and adenosine A3 receptors</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>11941</fpage><lpage>11952</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1183-11.2011</pub-id><pub-id pub-id-type="pmid">21849555</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Dennis SH, Jaafari N, Cimarosti H et al (2011) Oxygen/glucose deprivation induces a reduction in synaptic AMPA receptors on hippocampal CA3 neurons mediated by mGluR1 and adenosine A3 receptors. J Neurosci 31:11941&#x02013;11952. 10.1523/JNEUROSCI.1183-11.2011<pub-id pub-id-type="pmid">21849555</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>Stoddart</surname><given-names>LA</given-names></name><name><surname>Vernall</surname><given-names>AJ</given-names></name><name><surname>Briddon</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist</article-title><source>Neuropharmacology</source><year>2015</year><volume>98</volume><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.04.013</pub-id><pub-id pub-id-type="pmid">25937210</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">Stoddart LA, Vernall AJ, Briddon SJ et al (2015) Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist. Neuropharmacology 98:68&#x02013;77. 10.1016/j.neuropharm.2015.04.013<pub-id pub-id-type="pmid">25937210</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Stockwell</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Niazi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Protein phosphatase role in adenosine A1 receptor-induced AMPA receptor trafficking and rat hippocampal neuronal damage in hypoxia/reperfusion injury</article-title><source>Neuropharmacology</source><year>2016</year><volume>102</volume><fpage>254</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.11.018</pub-id><pub-id pub-id-type="pmid">26626486</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Stockwell J, Chen Z, Niazi M et al (2016) Protein phosphatase role in adenosine A1 receptor-induced AMPA receptor trafficking and rat hippocampal neuronal damage in hypoxia/reperfusion injury. Neuropharmacology 102:254&#x02013;265. 10.1016/j.neuropharm.2015.11.018<pub-id pub-id-type="pmid">26626486</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Stockwell</surname><given-names>J</given-names></name><name><surname>Cayabyab</surname><given-names>FS</given-names></name></person-group><article-title>Adenosine A1 receptor-mediated endocytosis of AMPA receptors contributes to impairments in long-term potentiation (LTP) in the middle-aged rat hippocampus</article-title><source>Neurochem Res</source><year>2016</year><volume>41</volume><fpage>1085</fpage><lpage>1097</lpage><pub-id pub-id-type="doi">10.1007/s11064-015-1799-3</pub-id><pub-id pub-id-type="pmid">26700433</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Chen Z, Stockwell J, Cayabyab FS (2016) Adenosine A1 receptor-mediated endocytosis of AMPA receptors contributes to impairments in long-term potentiation (LTP) in the middle-aged rat hippocampus. Neurochem Res 41:1085&#x02013;1097. 10.1007/s11064-015-1799-3<pub-id pub-id-type="pmid">26700433</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Baines</surname><given-names>AE</given-names></name><name><surname>Corr&#x000ea;a</surname><given-names>SAL</given-names></name><name><surname>Irving</surname><given-names>AJ</given-names></name><name><surname>Frenguelli</surname><given-names>BG</given-names></name></person-group><article-title>Differential trafficking of adenosine receptors in hippocampal neurons monitored using GFP- and super-ecliptic phluorin-tagged receptors</article-title><source>Neuropharmacology</source><year>2011</year><volume>61</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.02.005</pub-id><pub-id pub-id-type="pmid">21315741</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Baines AE, Corr&#x000ea;a SAL, Irving AJ, Frenguelli BG (2011) Differential trafficking of adenosine receptors in hippocampal neurons monitored using GFP- and super-ecliptic phluorin-tagged receptors. Neuropharmacology 61:1&#x02013;11. 10.1016/j.neuropharm.2011.02.005<pub-id pub-id-type="pmid">21315741</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Thauerer</surname><given-names>B</given-names></name><name><surname>Zur Nedden</surname><given-names>S</given-names></name><name><surname>Baier-Bitterlich</surname><given-names>G</given-names></name></person-group><article-title>Purine nucleosides: endogenous neuroprotectants in hypoxic brain</article-title><source>J Neurochem</source><year>2012</year><volume>121</volume><fpage>329</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07692.x</pub-id><pub-id pub-id-type="pmid">22335456</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Thauerer B, Zur Nedden S, Baier-Bitterlich G (2012) Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J Neurochem 121:329&#x02013;342. 10.1111/j.1471-4159.2012.07692.x<pub-id pub-id-type="pmid">22335456</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>